Data / Research funding / HIV/AIDS
HIV/AIDS: 5,305 NIH awards ($13.2B) to 501 organizations
5,305 NIH awards ($13.2B) in the NIH spending category HIV/AIDS, to 501 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 5,305 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $472,070,715 | December 1, 2024 | November 30, 2025 | CURRIER, JUDITH S. | reporter.nih.gov |
| NIAID HIV and Other Infectious Diseases Clinical Research Support Services (CRSS) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $417,904,831 | August 15, 2023 | August 14, 2024 | STROKES, BAMBRA | reporter.nih.gov |
| HIV Vaccines Clinical Trials Network Leadership and Operations Center | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $244,071,463 | June 29, 2006 | November 30, 2027 | COREY, LAWRENCE | reporter.nih.gov |
| HIV Prevention Trials Network Leadership and Operations Center | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $213,590,410 | June 1, 2006 | November 30, 2027 | COHEN, MYRON SCOTT | reporter.nih.gov |
| HIV and Other Infectious Diseases Clinical Research Support Services (CRSS) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $198,645,463 | August 15, 2025 | August 14, 2026 | STOKES, BAMBRA | reporter.nih.gov |
| HIV Vaccine Trials Network Laboratory Center | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $177,480,054 | June 29, 2006 | November 30, 2027 | MCELRATH, MARGARET JULIANA | reporter.nih.gov |
| SDMC: HIV Vaccine Trials Network | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $156,744,802 | June 29, 2006 | November 30, 2027 | GILBERT, PETER B. | reporter.nih.gov |
| Consortium for HIV/AIDS Vaccine Development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $145,502,241 | July 1, 2019 | June 30, 2026 | BURTON, DENNIS R. | reporter.nih.gov |
| Induction of protective antibodies for HIV vaccine development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $143,048,158 | July 15, 2019 | June 30, 2026 | HAYNES, BARTON F. | reporter.nih.gov |
| Consortium for Advancing Management and Prevention of Cancer in People with HIV | NIH | National Cancer Institute | 2021 to 2025 | $106,635,299 | August 29, 2006 | August 31, 2030 | SPARANO, JOSEPH A. | reporter.nih.gov |
| CANCER THERAPY EVALUATION PROGRAM INFORMATICS & COMPUTER SUPPORT | NIH | National Cancer Institute | 2021 to 2025 | $86,933,457 | July 1, 2022 | June 30, 2026 | RAJU, SUDHIR | reporter.nih.gov |
| Statistical and Data Management Center (SDMC), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $84,840,845 | June 29, 2006 | November 30, 2027 | HUGHES, MICHAEL DAVID | reporter.nih.gov |
| Partnering for Precision Medicine: A Collaborative Services Center for the All of Us Program | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $81,257,090 | January 1, 2024 | September 14, 2026 | SMITH, STEPHEN | reporter.nih.gov |
| IMPAACT Leadership Group | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $77,468,129 | December 1, 2024 | November 30, 2027 | NACHMAN, SHARON A | reporter.nih.gov |
| TASK ORDER 4A SITE STUDY SETUP: CTSU IDIQ | NIH | National Cancer Institute | 2022 to 2025 | $77,467,748 | August 1, 2022 | July 31, 2026 | PATRICHUK, LUCILLE | reporter.nih.gov |
| HPTN SDMC: HPTN 096 Getting to Zero among Highest HIV Incidence (HHI) Men who have Sex with Men (MSM) in the American South: Testing an Integrated Strategy | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $74,729,762 | June 29, 2006 | November 30, 2027 | DONNELL, DEBORAH J | reporter.nih.gov |
| Pediatric HIV/AIDS Cohort Study (PHACS) 2020 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $71,153,847 | September 18, 2020 | July 31, 2026 | WILLIAMS, PAIGE L | reporter.nih.gov |
| California National Primate Research Center | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $70,585,773 | May 1, 1997 | April 30, 2028 | ATKINSON, SIMON J. | reporter.nih.gov |
| Support for National Primate Research Center | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $70,297,738 | May 1, 1997 | April 30, 2029 | NAGEL, BONNIE J. | reporter.nih.gov |
| NIAID CLINICAL SITE MONITORING | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $68,539,045 | February 1, 2023 | January 31, 2024 | SMITH, KIMBERLY | reporter.nih.gov |
| Washington National Primate Research Center | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $66,616,318 | June 10, 1997 | April 30, 2027 | OSTENDORF, MARI | reporter.nih.gov |
| Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $61,029,344 | September 30, 2019 | March 31, 2027 | URDAHL, KEVIN | reporter.nih.gov |
| Emory National Primate Research Center | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $59,605,748 | May 1, 1997 | April 30, 2026 | LEE, JOON SUP | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $59,316,664 | August 28, 1996 | June 30, 2026 | DRAETTA, GIULIO FRANCESCO | reporter.nih.gov |
| SDMC - IMPAACT Leadership Group | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $59,233,299 | June 29, 2006 | November 30, 2027 | SHAPIRO, DAVID ERIC | reporter.nih.gov |
| AIDS Clinical Trial Group Laboratory Center | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $56,714,107 | January 1, 2014 | November 30, 2027 | ALDROVANDI, GRACE M | reporter.nih.gov |
| Tulane National Primate Research Center | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $52,341,995 | May 9, 1997 | April 30, 2028 | HAMM, L LEE | reporter.nih.gov |
| DAIDS Quality Assurance, Quality Control and Inspection Readiness Support Services | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $51,529,857 | April 17, 2025 | April 16, 2026 | reporter.nih.gov | |
| Wisconsin National Primate Research Center Support | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $50,984,900 | June 10, 1997 | April 30, 2027 | GREJNER-BRZEZINSKA, DOROTA A. | reporter.nih.gov |
| Clinical Research Products Management Center (CRPMC) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $46,852,833 | June 16, 2025 | June 15, 2026 | REMGSAMAI-NHE, CARINA | reporter.nih.gov |
| The Southwest National Primate Research Center | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $46,064,371 | June 6, 1999 | April 30, 2026 | SCHLESINGER, LARRY S. | reporter.nih.gov |
| SUPPORT SERVICES OF THE HIV AIDS CLINICAL TRIAL NETWORKS | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $45,166,816 | November 30, 2022 | November 29, 2025 | DRIVER, BARBARA | reporter.nih.gov |
| Biological and Emerging Infections Research Resources Program (BEI-RRP): HIV/AIDS | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $44,214,194 | October 16, 2023 | October 15, 2025 | RASHID, SUJATHA | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $41,720,565 | June 1, 1997 | November 30, 2025 | FERRIS, ROBERT L. | reporter.nih.gov |
| Regional Oncology Research Center | NIH | National Cancer Institute | 2021 to 2025 | $40,980,320 | May 7, 1997 | May 31, 2027 | NELSON, WILLIAM GEORGE | reporter.nih.gov |
| LC: HIV PREVENTION TRIALS NETWORK | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $40,489,166 | June 1, 2006 | November 30, 2027 | ESHLEMAN, SUSAN H | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $39,144,749 | September 1, 1998 | August 31, 2027 | PARK, BEN HO | reporter.nih.gov |
| Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $38,435,039 | September 30, 2019 | September 29, 2026 | FORTUNE, SARAH | reporter.nih.gov |
| Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Scientific Leadership Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $36,023,354 | January 25, 2023 | January 14, 2030 | HIGHTOW-WEIDMAN, LISA B | reporter.nih.gov |
| Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $35,184,139 | August 1, 2021 | July 31, 2026 | COLER, RHEA | reporter.nih.gov |
| Production of Aluminum Based Adjuvants | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $34,078,534 | September 20, 2017 | December 31, 2026 | MACK, FRED | reporter.nih.gov |
| CFAR Network of Integrated Clinical Systems (CNICS) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $32,404,861 | September 30, 2006 | August 31, 2026 | SAAG, MICHAEL S. | reporter.nih.gov |
| Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $32,243,461 | September 22, 2022 | October 9, 2029 | MEGAZZINI, KAREN | reporter.nih.gov |
| NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $31,474,131 | September 26, 2025 | September 25, 2026 | reporter.nih.gov | |
| IPP - DRUG DEVELOPMENT SUPPORT FOR CTEP | NIH | National Cancer Institute | 2022 to 2025 | $31,120,905 | July 1, 2022 | June 30, 2026 | MILLER, LAUREN | reporter.nih.gov |
| Pediatric Adolescent Virus Elimination (PAVE) Martin Delaney Collaboratory | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $30,092,882 | August 16, 2021 | April 30, 2027 | PERSAUD, DEBORAH | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $29,642,385 | September 12, 1997 | November 30, 2025 | RATHMELL, WENDY KIMRYN | reporter.nih.gov |
| BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $29,083,069 | August 16, 2021 | April 30, 2027 | MONTANER, LUIS J | reporter.nih.gov |
| Case Comprehensive Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $28,812,474 | August 1, 1997 | March 31, 2030 | SCHWARTZ, GARY K | reporter.nih.gov |
| REACH: Research Enterprise to Advance a Cure for HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $27,533,114 | August 16, 2021 | April 30, 2027 | JONES, R. BRAD | reporter.nih.gov |
| HOPE - HIV Obstruction by Programmed Epigenetics | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $27,293,591 | August 16, 2021 | April 30, 2027 | OTT, MELANIE MARIA | reporter.nih.gov |
| Delaney AIDS Research Enterprise to Cure HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $26,967,938 | August 16, 2021 | April 30, 2027 | DEEKS, STEVEN GRANT | reporter.nih.gov |
| The DC Cohort: A Longitudinal Population-Based Cohort Study of People Living with HIV in Washington, DC | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $26,415,291 | June 1, 2020 | June 30, 2030 | CASTEL, AMANDA DERRYCK | reporter.nih.gov |
| B and T Cell Biology of Protection from and Eradication of SIV/SHIV Infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $26,314,793 | June 1, 2022 | May 31, 2027 | HUNTER, ERIC | reporter.nih.gov |
| Collaboratory of AIDS Researchers for Eradication (CARE) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $26,234,170 | August 16, 2021 | April 30, 2027 | MARGOLIS, DAVID M. | reporter.nih.gov |
| ERASE HIV: Enterprise for Research and Advancements to Stop and Eradicate HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $25,334,968 | August 16, 2021 | June 12, 2026 | PAIARDINI, MIRKO | reporter.nih.gov |
| The Johns Hopkins Center for AIDS Research (JHU CFAR) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $24,770,118 | May 2, 2012 | April 30, 2027 | CHAISSON, RICHARD E. | reporter.nih.gov |
| University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $24,477,809 | February 1, 2007 | November 30, 2027 | ERON, JOSEPH J | reporter.nih.gov |
| CRISPR for Cure | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $24,038,480 | August 16, 2021 | April 30, 2027 | KHALILI, KAMEL | reporter.nih.gov |
| AIDS and Cancer Specimen Resource (ACSR) | NIH | National Cancer Institute | 2021 to 2025 | $24,013,599 | September 23, 2013 | August 31, 2026 | BETHONY, JEFFREY MICHAEL | reporter.nih.gov |
| Data Analysis and Coordination Center for the MACS-WIHS Combined Cohort Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $23,837,604 | April 9, 2019 | September 30, 2026 | GANGE, STEPHEN J | reporter.nih.gov |
| SDMC: HIV Prevention Trials Network | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $23,565,144 | June 29, 2006 | March 31, 2022 | DONNELL, DEBORAH J | reporter.nih.gov |
| University of Washington/Fred Hutch Center for AIDS Research | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $23,344,932 | March 1, 1997 | May 31, 2028 | CELUM, CONNIE L | reporter.nih.gov |
| I4C 2.0: Immunotherapy for Cure | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $23,329,181 | August 16, 2021 | April 30, 2027 | BAROUCH, DAN H. | reporter.nih.gov |
| SF Bay Area MACS/WIHS Combined Cohort Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $23,128,905 | April 1, 2019 | September 30, 2026 | TIEN, PHYLLIS C | reporter.nih.gov |
| UCSF-Bay Area Center for AIDS Research | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $22,420,938 | March 1, 1997 | June 30, 2027 | GANDHI, MONICA | reporter.nih.gov |
| CTSU CORE SUPPORT SERVICES AND THE CTSU ENTERPRISE OF SYSTEMS - TASK AREA II | NIH | National Cancer Institute | 2021 | $22,304,622 | August 31, 2020 | August 30, 2021 | MARTIER, KAREN | reporter.nih.gov |
| Los Angeles CRS for the MACS/WIHS Combined Cohort Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $22,107,486 | April 15, 2019 | September 30, 2026 | MIMIAGA, MATTHEW JAMES | reporter.nih.gov |
| University of Pittsburgh MACS/WIHS CCS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $21,988,029 | April 1, 2019 | September 30, 2026 | RINALDO, CHARLES R | reporter.nih.gov |
| SOSIP-NP/mRNA combination for novel preventive and therapeutic HIV-1 vaccine regimens | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $21,986,953 | September 2, 2022 | June 30, 2027 | WILLIAMS, WILTON B | reporter.nih.gov |
| Chemistry Services for the Division of Translational Toxicology (HIV testing program) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $21,918,775 | July 30, 2014 | January 31, 2026 | reporter.nih.gov | |
| UZ-UCSF CTU | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $21,624,239 | September 9, 2025 | November 30, 2027 | CHIRENJE, ZVAVAHERA MIKE | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $21,571,641 | August 1, 1997 | November 30, 2027 | CARPTEN, JOHN D. | reporter.nih.gov |
| UCLA AIDS Prevention and Treatment Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $21,546,764 | February 1, 2007 | November 30, 2027 | LANDOVITZ, RAPHAEL J | reporter.nih.gov |
| Boston HIV CTU | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $21,445,869 | January 15, 2007 | November 30, 2027 | KURITZKES, DANIEL R. | reporter.nih.gov |
| LOGISTICAL AND IT SUPPORT FOR THE NCI CENTRAL INSTITUTIONAL REVIEW BOARD (CIRB) | NIH | National Cancer Institute | 2021 to 2023 | $21,394,060 | September 1, 2019 | August 31, 2024 | VALMONTE, CLAUDINE | reporter.nih.gov |
| Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $21,023,937 | April 1, 2019 | September 30, 2026 | SHARMA, ANJALI | reporter.nih.gov |
| Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $21,007,836 | April 1, 2019 | September 30, 2026 | MARGOLICK, JOSEPH B. | reporter.nih.gov |
| Center for AIDS Research at Emory University-CFAR RYSE Pathway Programs | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $20,704,145 | September 30, 2002 | May 31, 2027 | DEL RIO, CARLOS | reporter.nih.gov |
| International Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $20,605,531 | January 1, 2014 | November 30, 2027 | ALDROVANDI, GRACE M | reporter.nih.gov |
| Specialized Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2024 | $20,560,271 | July 1, 1996 | April 30, 2026 | SIMEONE, DIANE M | reporter.nih.gov |
| NIAID Specimen Repository | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $20,383,408 | September 30, 2025 | September 29, 2026 | PHIPPARD, DEBORAH | reporter.nih.gov |
| Reversing Immune Dysfunction for HIV-1 Eradication | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $20,001,273 | August 16, 2021 | October 31, 2026 | CHANDA, SUMIT K | reporter.nih.gov |
| SUPPORT SERVICES FOR THE PREVENTION AND TREATMENT THROUGH A COMPREHENSIVE CARE CONTINUUM FOR HIV-AFFECTED ADOLESCENTS IN RESOURCE CONSTRAINED SETTINGS IMPLEMENTATION SCIENCE NETWORK | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $19,936,404 | August 25, 2025 | August 24, 2026 | DRIVER, BARBARA | reporter.nih.gov |
| Northwestern CORE Clinical Research Site: Trans-omics for HIV/AIDS Research | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $19,790,656 | April 10, 2019 | September 30, 2026 | WOLINSKY, STEVEN M | reporter.nih.gov |
| San Diego Center for AIDS Research (SD CFAR) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $19,569,961 | April 1, 1997 | March 31, 2028 | SMITH, DAVID MITCHELL | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $19,528,719 | June 1, 1997 | June 30, 2028 | STEIDL, ULRICH | reporter.nih.gov |
| North American AIDS Cohorts on Collaboration and Design (NAACCORD) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $19,377,019 | July 1, 2006 | April 30, 2027 | ALTHOFF, KERI NICOLE | reporter.nih.gov |
| Baylor College of Medicine Cancer Center - Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $19,034,443 | July 1, 2007 | June 30, 2030 | REDDY, PAVAN | reporter.nih.gov |
| A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $18,851,827 | September 25, 2020 | March 31, 2027 | HAVLIR, DIANE V | reporter.nih.gov |
| Third Coast Center for AIDS Research | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $18,823,279 | April 9, 2015 | July 31, 2030 | MUSTANSKI, BRIAN | reporter.nih.gov |
| Expanding HOPE Liver Transplantation: Understanding Opportunistic Infection and Cancer Risk | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $18,807,472 | August 1, 2018 | August 31, 2030 | DURAND, CHRISTINE MARIE | reporter.nih.gov |
| Weill Cornell Medicine - Rutgers New Jersey Medical School Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $18,362,120 | January 10, 2007 | November 30, 2027 | GULICK, ROY M. | reporter.nih.gov |
| STORAGE AND DISTRIBUTION OF CLINICAL AGENTS | NIH | National Cancer Institute | 2023 to 2025 | $18,271,500 | February 1, 2023 | January 31, 2026 | MAHZAD, MEHRINFAR | reporter.nih.gov |
| UCSD Collaborative Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $18,116,542 | December 1, 2024 | November 30, 2027 | WILKIN, TIMOTHY J. | reporter.nih.gov |
| LOGISTICAL AND IT SUPPORT FOR THE NCI CENTRAL INDIVIDUAL REVIEW BOARD (CIRB) | NIH | National Cancer Institute | 2024 to 2025 | $18,014,450 | September 1, 2024 | August 31, 2026 | VALMONTE, CLAUDINE | reporter.nih.gov |
| The University of North Carolina Center for AIDS Research | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $18,001,859 | August 20, 2001 | May 31, 2027 | SWANSTROM, RONALD I | reporter.nih.gov |
| NIAID VIROLOGY QUALITY ASSURANCE (VQA) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $17,732,468 | June 21, 2025 | June 20, 2026 | DENNY, THOMAS | reporter.nih.gov |
| East Africa International Epidemiology Database to evaluate AIDS (IeDEA) Regional Consortium | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $17,134,028 | June 1, 2025 | June 30, 2026 | WOOLS-KALOUSTIAN, KARA KAY | reporter.nih.gov |
| Emory-CDC CTU | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $16,972,899 | December 1, 2024 | November 30, 2027 | KELLEY, COLLEEN F | reporter.nih.gov |
| International epidemiology Databases to Evaluate AIDS (IeDEA) Southern Africa. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $16,840,939 | May 1, 2025 | April 30, 2027 | ROHNER, ELIANE | reporter.nih.gov |
| UAB Center for AIDS Research (CFAR) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $16,269,163 | March 1, 1997 | May 31, 2029 | HEFFRON, RENEE A. | reporter.nih.gov |
| CWRU Center for Excellence on the Impact of Substance Use on HIV | NIH | National Institute on Drug Abuse | 2021 to 2025 | $16,213,687 | September 15, 2021 | May 31, 2027 | LEVINE, ALAN DAVID | reporter.nih.gov |
| University of Pennsylvania HIV Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $16,198,927 | February 1, 2007 | November 30, 2027 | FRANK, IAN | reporter.nih.gov |
| Central Africa International Epidemiology databases to Evaluate AIDS | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,957,495 | May 1, 2025 | April 30, 2027 | YOTEBIENG, MARCEL | reporter.nih.gov |
| Patient Safety Monitoring in International Laboratories (SMILE) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,856,301 | November 15, 2024 | November 14, 2025 | SOKOLL, LORI | reporter.nih.gov |
| District of Columbia Center for AIDS Research | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,682,969 | June 1, 2015 | June 30, 2030 | GREENBERG, ALAN EDWARD | reporter.nih.gov |
| MACS/WIHS Combined Cohort Study: Cook County Clinical Research Site (CC_CRS) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $15,678,563 | April 1, 2019 | September 30, 2026 | FRENCH, AUDREY | reporter.nih.gov |
| C3PO - The Candidate Clinical Correlate of Prognostic Outcome for TB Study | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $15,575,398 | July 1, 2024 | May 31, 2026 | NAHID, PAYAM | reporter.nih.gov |
| PERU Clinical Trial Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,506,525 | December 1, 2024 | November 30, 2027 | SANCHEZ, JORGE LUIS | reporter.nih.gov |
| Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,404,946 | May 1, 2025 | June 30, 2026 | CASTILHO, JESSICA L | reporter.nih.gov |
| PHRU-Setshaba Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,110,381 | December 1, 2024 | November 30, 2027 | GRAY, GLENDA E | reporter.nih.gov |
| Atlanta MACS/WIHS Combined Cohort Study Clinical Research Site | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $15,081,381 | April 1, 2019 | September 30, 2026 | LAHIRI, CECILE DELILLE | reporter.nih.gov |
| ERC Einstein-Rockefeller-CUNY Center for AIDS research | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,951,126 | May 1, 2017 | April 30, 2027 | GOLDSTEIN, HARRIS | reporter.nih.gov |
| Consolidated Basic Cancer Research Program | NIH | National Cancer Institute | 2021 to 2025 | $14,936,465 | April 1, 1997 | February 28, 2026 | ALTIERI, DARIO C | reporter.nih.gov |
| Center for AIDS Research | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,901,919 | April 1, 2005 | July 31, 2030 | TOMARAS, GEORGIA DORIS | reporter.nih.gov |
| UAB-MISS MACS/WIHS Combined Cohort Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $14,601,685 | April 1, 2019 | September 30, 2026 | KEMPF, MIRJAM-COLETTE | reporter.nih.gov |
| Single cell transcriptomic and epigenomic changes during chronic HIV infection and cocaine self-administration | NIH | National Institute on Drug Abuse | 2022 to 2025 | $14,516,969 | June 1, 2022 | March 31, 2027 | ZENG, HONGKUI | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $14,418,205 | July 14, 2000 | March 31, 2027 | BURKARD, MARK E | reporter.nih.gov |
| Surviving the HIV Epidemic (S/HE) in metropolitan Washington DC - Advancing knowledge through cohort studies | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $14,413,637 | April 1, 2019 | September 30, 2026 | KASSAYE, SEBLE G | reporter.nih.gov |
| Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) Consortium | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $14,399,999 | March 26, 2024 | February 28, 2029 | SAVIC, RADOJKA | reporter.nih.gov |
| IeDEA Asia-Pacific Research Collaboration | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,360,741 | July 15, 2006 | April 30, 2027 | SOHN, ANNETTE H | reporter.nih.gov |
| The RADAR cohort study of multilevel Influences on HIV and substance use | NIH | National Institute on Drug Abuse | 2021 to 2025 | $14,251,651 | April 15, 2014 | April 30, 2030 | MUSTANSKI, BRIAN | reporter.nih.gov |
| 1/2 REPRIEVE Extension for Trial Completion | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $14,219,228 | May 1, 2023 | April 30, 2027 | GRINSPOON, STEVEN K. | reporter.nih.gov |
| MACS/WIHS Combined Cohort Study: Brooklyn Clinical Research Site (Bklyn CRS) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $14,117,524 | April 1, 2019 | September 30, 2026 | GUSTAFSON, DEBORAH R. | reporter.nih.gov |
| Simian Vaccine Evaluation Unit: Maintenance of Nonhuman Primates | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,042,495 | April 1, 2020 | March 31, 2027 | AYE, PYONE | reporter.nih.gov |
| UNC MACS/WIHS Combined Cohort Study Clinical Research Site | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $13,957,792 | April 1, 2019 | September 30, 2026 | FLORIS-MOORE, MICHELLE | reporter.nih.gov |
| Simian Vaccine Evaluation Unit: Maintenance of Nonhuman Primates | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $13,765,907 | April 1, 2020 | March 31, 2027 | VILLINGER, FRANCOIS | reporter.nih.gov |
| HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $13,518,599 | April 1, 2007 | November 30, 2027 | BEKKER, LINDA-GAIL | reporter.nih.gov |
| Center for AIDS Prevention Studies (CAPS) | NIH | National Institute of Mental Health | 2021 to 2025 | $13,413,640 | September 1, 2001 | August 31, 2026 | JOHNSON, MALLORY O | reporter.nih.gov |
| CCTN - EVALUATION OF THE PHARMACOKINETIC PROFILE AND EFFECTS ON MECHANISMS OF CONTRACEPTION | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $13,364,848 | September 24, 2013 | September 30, 2025 | ALLEN, ERIN | reporter.nih.gov |
| REDS-IV-P DATA COORDINATING CENTER (DCC) PHASE 3 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $13,265,216 | April 1, 2024 | June 30, 2026 | CHAPMAN, KATHY | reporter.nih.gov |
| Pitt-Ohio State Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $13,065,770 | February 1, 2007 | November 30, 2027 | RIDDLER, SHARON | reporter.nih.gov |
| MACS/WIHS -CCS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $12,990,830 | April 1, 2019 | September 30, 2026 | ALCAIDE, MARIA LUISA | reporter.nih.gov |
| Vanderbilt HIV Clinical Trials Unit (CTU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,733,650 | February 1, 2007 | November 30, 2027 | HAAS, DAVID W | reporter.nih.gov |
| Case Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,725,521 | December 1, 2024 | November 30, 2027 | YENDEWA, GEORGE | reporter.nih.gov |
| RADXHIV VIRAL LOAD | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2025 | $12,723,739 | September 11, 2007 | July 31, 2028 | MANABE, YUKARI C | reporter.nih.gov |
| Tennessee Center for AIDS Research (TN-CFAR) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,615,712 | April 1, 2015 | June 30, 2030 | KOETHE, JOHN | reporter.nih.gov |
| Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,564,620 | September 1, 2021 | June 30, 2027 | KELLIS, MANOLIS | reporter.nih.gov |
| Georgetown University Lombardi Comprehensive Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $12,475,608 | July 1, 2025 | June 30, 2026 | WEINER, LOUIS M. | reporter.nih.gov |
| CURE CTU | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,461,433 | January 1, 2007 | November 30, 2027 | SPECTOR, STEPHEN A | reporter.nih.gov |
| The Y-SCORCH Data Generation Center at Yale for Single-Cell Opioid Responses in the Context of HIV | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,331,452 | August 1, 2020 | July 31, 2026 | SPUDICH, SERENA S | reporter.nih.gov |
| Columbia Collaborative HIV/AIDS Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,286,513 | February 1, 2007 | November 30, 2027 | SOBIESZCZYK, MAGDALENA ELZBIETA | reporter.nih.gov |
| AIDS Linked to the IntraVenous Experience (ALIVE) Study | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,226,379 | January 1, 2014 | May 31, 2030 | MEHTA, SHRUTI H | reporter.nih.gov |
| Tulane National Primate Research Center AIDS SPF Breeding Colony Maintenance | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $12,169,635 | July 1, 2017 | June 30, 2029 | RUSSELL-LODRIGUE, KASI E | reporter.nih.gov |
| Rustbelt Center for AIDS Research (Case/UHC-Pitt CFAR) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $12,035,397 | April 1, 1997 | April 30, 2027 | KARN, JONATHAN | reporter.nih.gov |
| Center for HIV Identification, Prevention and Treatment Services | NIH | National Institute of Mental Health | 2021 to 2025 | $12,008,424 | September 30, 1997 | December 31, 2026 | LANDOVITZ, RAPHAEL J | reporter.nih.gov |
| PDB MANAGEMENT BY THE RESEARCH COLLABORATORY FOR STRUCTURAL BIOINFORMATICS | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $12,006,722 | August 1, 2019 | September 18, 2024 | BURLEY, STEPHEN K | reporter.nih.gov |
| TB-RICC 3.0 | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $11,818,694 | April 1, 2023 | March 31, 2028 | ELLNER, JERROLD J. | reporter.nih.gov |
| Preclinical and Translational Vaccine Development for HIV and Other Candidate Agents (PTVDS) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $11,597,222 | December 1, 2024 | November 30, 2025 | DENNY, TOM | reporter.nih.gov |
| Health Outcomes around Pregnancy and Exposure to HIV/ARV (HOPE): Extending the Reach of PHACS to Examine Women's Health | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $11,578,258 | September 1, 2020 | June 30, 2026 | WILLIAMS, PAIGE L | reporter.nih.gov |
| Reagent Resource Support Program for AIDS Vaccine Development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $11,522,629 | April 8, 2018 | April 7, 2025 | FREMONT, VALERIE | reporter.nih.gov |
| Using Longitudinal Research to Engage African American and Latinx Sexual- and Gender-Minority Youth in the HIV Prevention and Care Continua and Reduce HIV/AIDS-Related Disparities | NIH | National Institute on Drug Abuse | 2021 to 2024 | $11,452,208 | August 15, 2015 | June 30, 2025 | KIPKE, MICHELE D. | reporter.nih.gov |
| WaNPRC Macaca nemestrina SPF Breeding Colony | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $11,361,503 | September 30, 2002 | June 30, 2028 | FULLER, DEBORAH H. | reporter.nih.gov |
| KwaZulu-Natal Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,302,268 | December 1, 2024 | November 30, 2027 | ABDOOL KARIM, QUARRAISHA | reporter.nih.gov |
| Women HIV Cohort Study: HIV infection and treatment among women of reproductive age | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $11,285,317 | September 27, 2019 | August 31, 2025 | ALCAIDE, MARIA LUISA | reporter.nih.gov |
| The Johns Hopkins University-Blantyre Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,246,510 | February 15, 2007 | November 30, 2027 | TAHA, TAHA E | reporter.nih.gov |
| Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) reapplication | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,202,199 | March 15, 2007 | September 21, 2025 | SANNE, IAN MATTHIAS | reporter.nih.gov |
| Revealing the single cell determinants of brain relevant to persistent HIV infection and opioid use disorder | NIH | National Institute on Drug Abuse | 2021 to 2025 | $11,197,081 | September 30, 2021 | July 31, 2027 | RANA, TARIQ M | reporter.nih.gov |
| UCLA-CDU CFAR | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $11,094,755 | April 8, 2022 | March 31, 2027 | CURRIER, JUDITH S. | reporter.nih.gov |
| Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional mice | NIH | National Institute on Drug Abuse | 2021 to 2025 | $11,085,606 | May 15, 2021 | July 31, 2026 | KENNY, PAUL J. | reporter.nih.gov |
| Advancing Vaccine Adjuvant Research for Tuberculosis (TB) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $10,964,476 | September 30, 2022 | September 29, 2027 | BRITTON, WARWICK | reporter.nih.gov |
| Johns Hopkins University Baltimore India Clinical Trail Unit (JHUBI CTU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,947,708 | February 5, 2007 | November 30, 2027 | GUPTA, AMITA | reporter.nih.gov |
| Providence/Boston Center for AIDS Research (CFAR) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,929,611 | September 1, 1998 | June 30, 2028 | BECKWITH, CURT G | reporter.nih.gov |
| AIDS Clinical Trials Group (ACTG) DMC Activities | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,797,892 | December 1, 2020 | November 30, 2027 | MAGNUS, MANYA | reporter.nih.gov |
| CLINICAL TRIALS MONITORING SERVICE | NIH | National Cancer Institute | 2021 | $10,790,968 | May 1, 2017 | April 30, 2021 | ANDERSON, BARRY | reporter.nih.gov |
| Reagent Program for HIV and other Infectious Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $10,735,388 | October 15, 2023 | January 13, 2024 | RASHID, SUJATHA | reporter.nih.gov |
| STORAGE AND DISTRIBUTION OF CLINICAL AGENTS | NIH | National Cancer Institute | 2021 to 2022 | $10,577,768 | February 1, 2018 | January 31, 2023 | MEHRINFAR, MAHZAD | reporter.nih.gov |
| Addressing risk through Community Treatment for Infectious disease and Opioid use disorder Now (ACTION) among justice-involved populations | NIH | National Institute on Drug Abuse | 2021 to 2025 | $10,550,278 | September 30, 2020 | July 31, 2026 | SPRINGER, SANDRA ANN | reporter.nih.gov |
| ICAP Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,475,165 | December 1, 2020 | November 30, 2027 | EL-SADR, WAFAA M. | reporter.nih.gov |
| Nonhuman Primate (NHP) Core Functional Genomics Laboratory for AIDS Vaccine Research and Development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $10,303,422 | July 1, 2019 | June 30, 2020 | GALE, MICHAEL | reporter.nih.gov |
| University of Rochester HIV/AIDS Clinical Trials Unit Administrative Supplement | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,156,163 | August 26, 2025 | November 30, 2027 | KEEFER, MICHAEL C | reporter.nih.gov |
| Nonhuman Primate Core Humoral Immunology Laboratory for AIDS Vaccine Research and Development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $10,129,006 | March 30, 2024 | March 29, 2025 | SHEN, SHAUNNA | reporter.nih.gov |
| Thailand HIV/AIDS and Infectious Disease Clinical Trials Unit (THAI CTU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,070,868 | March 15, 2007 | November 30, 2027 | SUPPARATPINYO, KHUANCHAI | reporter.nih.gov |
| Obesogenic origins of maternal and child metabolic health involving dolutegravir (ORCHID) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $9,956,619 | September 25, 2020 | June 30, 2026 | ABRAMS, ELAINE JANINE | reporter.nih.gov |
| The Military HIV Research Program (MHRP) Clinical Trial Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,910,676 | December 10, 2013 | November 30, 2027 | ROBB, MERLIN L | reporter.nih.gov |
| The Johns Hopkins University - Uganda Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,910,249 | February 5, 2007 | November 30, 2027 | FOWLER, MARY GLENN | reporter.nih.gov |
| Botswana-Harvard T.H. Chan School of Public Health AIDS Initiative Partnership CTU | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,824,534 | February 1, 2007 | June 30, 2025 | LOCKMAN, SHAHIN | reporter.nih.gov |
| Expanded SPF Rhesus Macaque Breeding Colony for AIDS Research | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $9,705,199 | August 1, 2016 | August 31, 2028 | BOHM, RUDOLF PAUL | reporter.nih.gov |
| GHESKIO Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,655,243 | February 1, 2007 | November 30, 2027 | PAPE, JEAN WILLIAM | reporter.nih.gov |
| Expertise in Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines: Blocker Discovery | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $9,584,357 | September 30, 2025 | September 29, 2026 | SILVERA, PETER | reporter.nih.gov |
| Research Resource for Human Organs and Tissues | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $9,547,294 | January 9, 1989 | June 30, 2027 | BELL, THOMAS J | reporter.nih.gov |
| The Center for Innovation in Point-of-Care Technologies for HIV/AIDS and Emerging Infectious Diseases at Northwestern University (C-THAN) | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2025 | $9,495,667 | September 11, 2018 | July 31, 2028 | ACHENBACH, CHAD J | reporter.nih.gov |
| M-SCORCH: Methamphetamine use disorder data generation center for Single Cell Opioid Responses in the Context of HIV | NIH | National Institute on Drug Abuse | 2021 to 2025 | $9,490,616 | May 15, 2021 | February 28, 2027 | HO, YA-CHI | reporter.nih.gov |
| Miami Center for AIDS Research | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,391,980 | November 1, 2006 | May 31, 2027 | CHAKRABORTY, RANA | reporter.nih.gov |
| HIV Center for Clinical and Behavioral Studies | NIH | National Institute of Mental Health | 2021 to 2025 | $9,131,244 | September 30, 1987 | April 30, 2028 | REMIEN, ROBERT H | reporter.nih.gov |
| Immunology Quality Assessment (IQA) Program | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,088,186 | September 30, 2025 | September 29, 2026 | DENNY, THOMAS | reporter.nih.gov |
| Center for Interdisciplinary Research on AIDS | NIH | National Institute of Mental Health | 2021 to 2025 | $9,088,156 | September 30, 2001 | February 28, 2028 | KERSHAW, TRACE S | reporter.nih.gov |
| American Women: Assessing Risk Epidemiologically (AWARE - RFA) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $9,079,530 | August 18, 2022 | July 31, 2028 | SCHNALL, REBECCA | reporter.nih.gov |
| Digital, Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,011,446 | March 9, 2021 | February 28, 2027 | MIMIAGA, MATTHEW JAMES | reporter.nih.gov |
| A-Z Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,989,738 | February 1, 2007 | November 30, 2027 | GOEPFERT, PAUL A. | reporter.nih.gov |
| Maintenance of the SPF Breeding Colonies at Yerkes National Primate Research Center | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $8,820,543 | September 30, 2002 | May 31, 2026 | COHEN, JOYCE KIMBERLY | reporter.nih.gov |
| Microbiome, Metabolites, and Alcohol in HIV to Reduce CVD (META HIV CVD) | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $8,561,222 | September 10, 2021 | August 31, 2026 | FREIBERG, MATTHEW S | reporter.nih.gov |
| Simian Vaccine Evaluation Unit: Core Activities - Administrative and Technical Support | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,478,988 | April 1, 2020 | March 31, 2027 | LEWIS, MARK | reporter.nih.gov |
| International Epidemiology Databases to EvaluateAIDS (IeDEA) Renewal 4 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,392,710 | July 1, 2006 | July 2, 2026 | JAQUET, ANTOINE | reporter.nih.gov |
| San Francisco Bay Clinical Trials Unit (CTU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,314,128 | March 2, 2007 | November 30, 2027 | BUCHBINDER, SUSAN | reporter.nih.gov |
| Texas Developmental Center for AIDS Research | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,282,292 | April 23, 2021 | March 31, 2027 | GIORDANO, THOMAS P | reporter.nih.gov |
| Consortia for Innovative AIDS Research in Nonhuman Primates | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $8,268,168 | May 1, 2016 | April 30, 2022 | BAROUCH, DAN H. | reporter.nih.gov |
| Uncovering HIV/opioid effects in the brain at the single cell level: transcription, chromatin accessibility, and reservoir analysis in the SIV/cART/morphine/rhesus monkey model | NIH | National Institute on Drug Abuse | 2021 to 2025 | $8,243,787 | August 15, 2021 | June 30, 2027 | FOX, HOWARD S | reporter.nih.gov |
| The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,239,326 | January 15, 2008 | November 30, 2027 | GRINSZTEJN, BEATRIZ | reporter.nih.gov |
| Clinical Pharmacology Quality Assurance (CPQA) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $8,119,963 | May 30, 2025 | May 29, 2026 | MORSE, GENE | reporter.nih.gov |
| Comprehensive Resources for HIV Microbicides and Biomedical Prevention: Quality Assurance/ Quality Control (QA/QC) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $8,076,617 | July 15, 2022 | July 14, 2023 | SILVERA, PETER | reporter.nih.gov |
| LSUHSC-NO Comprehensive Alcohol-HIV/AIDS Research Center (CARC) | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $8,052,951 | December 1, 1996 | August 31, 2030 | MOLINA, PATRICIA E. | reporter.nih.gov |
| cGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of a Nanoparticle Based HIV Envelope Vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $8,013,603 | August 30, 2022 | August 29, 2030 | HASSELL, THOMAS | reporter.nih.gov |
| Further expansion of the Southwest National Primate Research Center Specific Pathogen Free Rhesus Macaque Resource | NIH | Office of the Director, National Institutes of Health | 2023 | $8,000,000 | September 8, 2023 | April 30, 2027 | MALLORY, AMBER | reporter.nih.gov |
| CHARTER Plus: A resource for cutting-edge research on neurological function and mental health in people with HIV and substance use disorders across the lifespan | NIH | National Institute of Mental Health | 2022 to 2025 | $7,973,681 | February 1, 2022 | November 30, 2026 | LETENDRE, SCOTT L | reporter.nih.gov |
| Implementation Research Strategies for Heart, Lung, and Blood Co-morbidities in People Living with HIV - Research Coordinating Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $7,961,623 | September 30, 2020 | August 31, 2025 | SCHECHTMAN, KENNETH B. | reporter.nih.gov |
| Upgrading Institutional Capacity with a BSL-3 Facility for Multidisciplinary Biomedical Research | NIH | Office of the Director, National Institutes of Health | 2025 | $7,947,160 | September 15, 2025 | March 31, 2028 | MCELRATH, MARGARET JULIANA | reporter.nih.gov |
| SUPPORT SERVICES FOR THE CTEP PHARMACEUTICAL MANAGEMENT BRANCH (PMB) | NIH | National Cancer Institute | 2022 to 2025 | $7,922,356 | September 1, 2022 | August 31, 2026 | GRAY, ARIE | reporter.nih.gov |
| External Quality Assurance Program Oversight Laboratory (EQAPOL) | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $7,902,910 | September 30, 2024 | September 29, 2031 | DENNY, THOMAS | reporter.nih.gov |
| Epidemiology and Impact of the HIV, NCD, and Urbanization Syndemic in Africa | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,818,042 | February 2, 2021 | January 31, 2027 | CHANG, LARRY WILLIAM | reporter.nih.gov |
| PDB Management by the Research Collaboratory for Structural Bioinformatics | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $7,760,000 | September 30, 2024 | July 31, 2029 | BURLEY, STEPHEN K | reporter.nih.gov |
| University of California Launching Future Leaders in Global Health Research Training Program | NIH | Fogarty International Center | 2021 to 2025 | $7,742,746 | July 1, 2025 | June 30, 2026 | COHEN, CRAIG R | reporter.nih.gov |
| Pediatric Scientist Development Program | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $7,708,555 | December 1, 1986 | June 30, 2028 | PERMAR, SALLIE R. | reporter.nih.gov |
| Seattle Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $7,698,581 | February 1, 2007 | November 30, 2027 | MCELRATH, MARGARET JULIANA | reporter.nih.gov |
| Maintenance of an SPF Macaque Breeding Colony for AIDS Research | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $7,568,566 | August 9, 2001 | January 31, 2029 | RUSSELL-LODRIGUE, KASI E | reporter.nih.gov |
| DRUG DEVELOPMENT SUPPORT FOR THE CANCER THERAPY EVALUATION PROGRAM (CTEP) | NIH | National Cancer Institute | 2021 | $7,562,000 | July 1, 2015 | June 30, 2022 | SAUNDERS, JOAN | reporter.nih.gov |
| Ad26 Based Therapeutic Vaccines for HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $7,518,476 | May 12, 2020 | April 30, 2027 | BAROUCH, DAN H. | reporter.nih.gov |
| The International URBAN Alcohol Research Collaboration on HIV/AIDS (ARCH) Center | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $7,511,308 | September 10, 2021 | August 31, 2027 | SAMET, JEFFREY H. | reporter.nih.gov |
| Extended follow-up of randomized participants in the INSIGHT START trial | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $7,453,707 | May 17, 2019 | April 30, 2025 | GRUND, BIRGIT | reporter.nih.gov |
| Single cell determinants of brain in the context of viral persistence in SIV/cART/cocaine non-human primates | NIH | National Institute on Drug Abuse | 2023 to 2025 | $7,434,979 | June 1, 2023 | February 29, 2028 | RANA, TARIQ M | reporter.nih.gov |
| Boston Alcohol Research Collaboration on HIV/AIDS - Comorbidity Center (Boston ARCH CC) | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $7,406,307 | September 22, 2021 | August 31, 2027 | STEIN, MICHAEL D | reporter.nih.gov |
| Cohort Studies of HIV/AIDS and Substance Use in Miami | NIH | National Institute on Drug Abuse | 2025 | $7,372,834 | September 30, 2025 | June 30, 2030 | BAUM, MARIANNA K | reporter.nih.gov |
| Northern Pacific Global Health Leadership, Education, and Development for Early-career Researchers (NPGH LEADERs) | NIH | Fogarty International Center | 2021 to 2025 | $7,366,373 | July 1, 2025 | June 30, 2026 | ZUNT, JOSEPH RAYMOND | reporter.nih.gov |
| Harmonist: A Scalable Toolkit for Standardizing and Coordinating Data Sharing Across International Research Networks | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $7,298,694 | May 25, 2016 | April 30, 2027 | DUDA, STEPHANY NORAH | reporter.nih.gov |
| UJMT LAUNCH: Training the next generation of leaders in global health research | NIH | Fogarty International Center | 2021 to 2025 | $7,230,452 | September 1, 2025 | June 30, 2026 | CHI, BENJAMIN H. | reporter.nih.gov |
| MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE) | NIH | National Institute on Drug Abuse | 2021 to 2024 | $7,177,379 | September 30, 2013 | April 30, 2026 | GORBACH, PAMINA MAE | reporter.nih.gov |
| NeMO Archive: SCORCH Support, Coordination and Outreach | NIH | National Institute on Drug Abuse | 2021 to 2025 | $7,111,105 | August 1, 2020 | June 30, 2030 | WHITE, OWEN R | reporter.nih.gov |
| Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposure | NIH | National Institute on Drug Abuse | 2023 to 2025 | $7,084,951 | May 15, 2023 | March 31, 2028 | NDHLOVU, LISHOMWA C | reporter.nih.gov |
| Alcohol Research Consortium in HIV: Ending the HIV Epidemic through interventions and Epidemiology at the intersection of the alcohol and HIV care Continua | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $7,057,359 | September 10, 2021 | August 31, 2027 | MCCAUL, MARY E | reporter.nih.gov |
| Enhanced Cohort methods for HIV Research and Epidemiology (ENCORE) in the United States | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $7,056,913 | August 9, 2022 | December 31, 2027 | COONEY, ERIN EILEEN | reporter.nih.gov |
| Production of Pedigreed SPF Rhesus Macaques | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $6,908,065 | September 30, 2000 | January 31, 2028 | OATES, RHONDA S | reporter.nih.gov |
| Ethno-epidemiology of HCV, HIV and Overdose associated with Drug Markets and Drug Tourism | NIH | National Institute on Drug Abuse | 2021 to 2024 | $6,868,774 | April 1, 2020 | January 31, 2026 | STRATHDEE, STEFFANIE A. | reporter.nih.gov |
| Native-like Envelope Trimer Therapeutic Vaccination for Induction of Broadly Neutralizing Antibodies to Facilitate HIV Functional Cure | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,813,637 | April 14, 2020 | July 31, 2027 | RIDDLER, SHARON | reporter.nih.gov |
| DATA AND SPECIMEN HUB (DASH) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $6,809,935 | December 1, 2021 | November 30, 2022 | VAVRECK, DEBRA | reporter.nih.gov |
| B and T Cell Biology of Protection from and Eradication of SIV/SHIV Infection - Administrative Supplement | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $6,714,942 | June 1, 2016 | May 31, 2022 | HUNTER, ERIC | reporter.nih.gov |
| Complementing broadly neutralizing antibodies and autologous responses to restrict virus escape and durably suppress HIV-1 | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $6,685,272 | April 11, 2022 | March 31, 2027 | BAR, KATHARINE JUNE | reporter.nih.gov |
| Aurum Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,678,965 | December 1, 2020 | November 30, 2027 | CHURCHYARD, GAVIN JOHN | reporter.nih.gov |
| Researching Interventions and Implementation Strategies to Evaluate the Health and Development of Children Affected by HIV | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $6,635,347 | September 18, 2025 | August 31, 2030 | JOHN-STEWART, GRACE C. | reporter.nih.gov |
| California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ Populations | NIH | National Cancer Institute | 2021 to 2025 | $6,605,241 | September 12, 2019 | July 31, 2026 | PALEFSKY, JOEL MICHAEL | reporter.nih.gov |
| Stellenbosch University Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,524,563 | April 15, 2007 | November 30, 2027 | HESSELING, ANNEKE CATHARINA | reporter.nih.gov |
| Multi-level Optimization of the Cervical Cancer Screening Process in Diverse Settings & Populations (METRICS) | NIH | National Cancer Institute | 2021 to 2023 | $6,487,883 | April 10, 2018 | March 31, 2025 | HUGHES, AMY E | reporter.nih.gov |
| Harnessing the power of text messaging to reduce HIV incidence in adolescent males across the United States | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $6,477,724 | September 23, 2021 | December 8, 2027 | YBARRA, MICHELE L. | reporter.nih.gov |
| Whole Person Reference Physiome Research and Coordination Center | NIH | National Center for Complementary & Integrative Health | 2025 | $6,476,031 | August 8, 2025 | July 31, 2028 | SNYDER, MICHAEL P. | reporter.nih.gov |
| Dissecting the mechanisms of HIV resistance in vivo to broadly neutralizing antibodies | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $6,461,018 | August 9, 2022 | May 31, 2027 | HERSCHHORN, ALON | reporter.nih.gov |
| The Cleveland Digestive Diseases Research Core Center (DDRCC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,425,666 | February 15, 2015 | August 31, 2030 | COMINELLI, FABIO | reporter.nih.gov |
| Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,398,428 | July 1, 2021 | June 30, 2027 | GENGENBACHER, MARTIN ALFONS | reporter.nih.gov |
| Effectiveness of Relationship Education for Reducing HIV Incidence in Men Who Have Sex with Men | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $6,366,745 | April 1, 2021 | March 21, 2025 | NEWCOMB, MICHAEL E | reporter.nih.gov |
| The HIV and Alcohol Research center focused on Polypharmacy (HARP) | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $6,323,238 | September 10, 2021 | August 31, 2026 | JUSTICE, AMY CAROLINE | reporter.nih.gov |
| DUAL AFFINITY RE-TARGETING (DART) MOLECULES FOR HIV-1 SUPPRESSION | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $6,287,950 | September 15, 2015 | July 14, 2023 | NORDSTROM, JEFFREY | reporter.nih.gov |
| Defining the mechanisms of HIV resistance to bNAbs in humans | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $6,279,096 | July 5, 2022 | April 30, 2027 | CASKEY, MARINA | reporter.nih.gov |
| Single Cell Transcriptomics of the Cocaine Use Disorder in the Context of HIV | NIH | National Institute on Drug Abuse | 2022 to 2025 | $6,266,450 | June 15, 2022 | March 31, 2027 | CHENG, CHRISTINE | reporter.nih.gov |
| Ancillary Studies of NAFLD and NASH in HIV infected Adults | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $6,132,391 | March 21, 2020 | January 31, 2026 | CHALASANI, NAGA P | reporter.nih.gov |
| Partnership for Global Health Research Training Program(Renewal) | NIH | Fogarty International Center | 2021 to 2025 | $6,122,088 | July 1, 2017 | June 30, 2027 | FAWZI, WAFAIE W | reporter.nih.gov |
| A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in Botswana | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $6,096,179 | September 5, 2023 | June 30, 2028 | SHAPIRO, ROGER L | reporter.nih.gov |
| Design and testing of immunogens to elicit 10E8-like broadly neutralizing antibodies against HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,090,710 | July 8, 2019 | August 31, 2029 | SCHIFFNER, TORBEN | reporter.nih.gov |
| Johns Hopkins HIV Clinical Cohort | NIH | National Institute on Drug Abuse | 2021 to 2024 | $5,955,256 | July 1, 2014 | March 31, 2026 | MOORE, RICHARD DOUGLAS | reporter.nih.gov |
| Partnership for Prevention of HPV-Associated Cancers in People Living with HIV: Brazil, Mexico, and Puerto Rico | NIH | National Cancer Institute | 2021 to 2025 | $5,948,066 | September 20, 2019 | July 31, 2026 | ELLSWORTH, GRANT B. | reporter.nih.gov |
| Defining the impact of drug use on immune function and fitness against HIV-1 | NIH | National Institute on Drug Abuse | 2021 to 2025 | $5,880,000 | May 1, 2021 | April 30, 2026 | SHALEK, ALEX K | reporter.nih.gov |
| Optimizing HIV prevention for high-risk methamphetamine-using men who have sex with men | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $5,855,396 | April 8, 2022 | April 30, 2027 | GROV, CHRISTIAN | reporter.nih.gov |
| Effects of HIV, Cocaine, and Prolonged ART Use on Subclinical Cardiovascular Disease | NIH | National Institute on Drug Abuse | 2021 to 2024 | $5,744,264 | June 1, 2016 | April 30, 2025 | LAI, SHENGHAN | reporter.nih.gov |
| Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA) | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $5,703,886 | September 10, 2021 | August 31, 2026 | CROPSEY, KAREN L | reporter.nih.gov |
| Nonhuman Primate (NHP) Core Cellular Immunology Laboratory for AIDS Vaccine Research Development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $5,634,048 | June 1, 2023 | May 31, 2024 | KAUR, AMITINDER | reporter.nih.gov |
| Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,559,114 | June 17, 2020 | January 31, 2027 | WALZL, GERHARD | reporter.nih.gov |
| Expansion and modification of animal housing and support spaces to increase production of the NIH U42 supported pigtailed macaque colony at Johns Hopkins University | NIH | Office of the Director, National Institutes of Health | 2022 | $5,500,152 | September 20, 2022 | May 31, 2027 | MANKOWSKI, JOSEPH L | reporter.nih.gov |
| 1/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $5,484,720 | September 20, 2021 | August 31, 2026 | KANER, ROBERT J | reporter.nih.gov |
| CNS Viral Persistence and Neuropsychiatric Perturbations in HIV: Single cell and Molecular Interrogation | NIH | National Institute of Mental Health | 2021 to 2025 | $5,419,683 | May 1, 2021 | February 28, 2027 | SPUDICH, SERENA S | reporter.nih.gov |
| Cellular Immunology Core Laboratory | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $5,413,068 | June 1, 2025 | May 31, 2026 | KAUR, AMITINDER | reporter.nih.gov |
| Functionally Defining HIV-Host Interactions During the Early HIV-1 Lifecycle | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $5,387,791 | March 1, 2020 | February 28, 2025 | HOPE, THOMAS | reporter.nih.gov |
| A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in Botswana | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $5,339,746 | February 20, 2018 | January 31, 2026 | SHAPIRO, ROGER L | reporter.nih.gov |
| Chicago Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,330,849 | February 1, 2007 | November 30, 2027 | ACHENBACH, CHAD J | reporter.nih.gov |
| Vancouver Drug Users Study: The Impacts of Evolving Drug Use Patterns on HIV/AIDS | NIH | National Institute on Drug Abuse | 2021 to 2024 | $5,321,290 | March 1, 2015 | April 30, 2026 | HAYASHI, KANNA | reporter.nih.gov |
| CASCADE Coordinating Center | NIH | National Cancer Institute | 2022 to 2025 | $5,257,059 | September 7, 2022 | May 31, 2027 | SIMINSKI, SUZANNE M. | reporter.nih.gov |
| Kidney Transplantation from Donors with HIV: Impact on Rejection and Long-term Outcomes | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $5,224,210 | May 25, 2023 | April 30, 2028 | DURAND, CHRISTINE MARIE | reporter.nih.gov |
| Biomedical Informatics Training Program at Stanford | NIH | National Library of Medicine | 2021 to 2025 | $5,216,659 | July 1, 1984 | June 30, 2027 | PLEVRITIS, SYLVIA KATINA | reporter.nih.gov |
| AIDS Subproject 4 | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $5,200,000 | September 23, 2013 | September 22, 2023 | HEBERT, CHARLES | reporter.nih.gov |
| HIV-1 Q23.17 Env: Engineering a novel immunogen to elicit broadly neutralizing antibodies | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,173,076 | June 23, 2021 | May 31, 2026 | SHAW, GEORGE M | reporter.nih.gov |
| High-throughput proteomics using submicroliter amounts of plasma for comprehensive assessment of the immune status | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $5,147,391 | April 9, 2020 | March 31, 2026 | STEEN, HANNO | reporter.nih.gov |
| Addressing alcohol misuse in HIV prevention and care: The Brown University Alcohol Research Center on HIV (ARCH) | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2024 | $5,146,588 | September 30, 2010 | May 31, 2026 | KAHLER, CHRISTOPHER W. | reporter.nih.gov |
| Identification of the Initial Targets of Transmission | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,125,048 | July 1, 2022 | June 30, 2027 | HOPE, THOMAS | reporter.nih.gov |
| Limited interaction cohort to identify determinants of viral suppression in MSM and transfeminine individuals living with HIV: A multilevel approach | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $5,007,595 | May 4, 2023 | March 21, 2025 | SULLIVAN, PATRICK SEAN | reporter.nih.gov |
| Reversing Immune Dysfunction for HIV-1 Eradication | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $5,001,807 | August 16, 2021 | October 31, 2021 | CHANDA, SUMIT K | reporter.nih.gov |
| Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Coordinating Center- Supplement | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $4,991,361 | July 3, 2021 | May 31, 2022 | LAVANGE, LISA | reporter.nih.gov |
| Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment | NIH | National Institute on Drug Abuse | 2021 to 2023 | $4,952,252 | August 1, 2019 | June 30, 2025 | MONTANER, LUIS J | reporter.nih.gov |
| Continued support for an SPF Macaca nemestrina breeding colony to provide animals to NIH funded HIV research projects | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $4,942,403 | September 21, 2006 | July 31, 2026 | HOPPER, LYDIA | reporter.nih.gov |
| Integrated Networks of Scholars in Global Health Research Training (INSIGHT) | NIH | Fogarty International Center | 2022 to 2025 | $4,936,480 | July 1, 2025 | June 30, 2027 | CHARURAT, MANHATTAN E | reporter.nih.gov |
| Fine Mechanisms of Adaptive NK Cell Formation Against HIV and SIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,922,128 | August 20, 2021 | July 31, 2027 | REEVES, ROGER KEITH | reporter.nih.gov |
| Antigen recognition and activation of HIV-specific B cell antigen receptors | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,911,145 | March 20, 2019 | July 31, 2029 | ALAM, S. MUNIR | reporter.nih.gov |
| Modeling drugs of abuse-HIV interactions using iPSC-derived human cerebral organoids | NIH | National Institute on Drug Abuse | 2021 to 2025 | $4,890,555 | September 30, 2021 | July 31, 2026 | SANNA, PIETRO P | reporter.nih.gov |
| Evolving Novel AAV Vectors for Gene Therapy to Cure HIV | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,872,750 | June 7, 2022 | May 31, 2027 | SACHA, JONAH B. | reporter.nih.gov |
| Strategically Engineered Multi-Antigen KSHV Vaccine: Integrating Humoral and Cellular Immunity for Effective Protection | NIH | National Cancer Institute | 2025 | $4,857,475 | August 7, 2025 | July 31, 2029 | WU, TING-TING | reporter.nih.gov |
| Ending HIV: Bringing Integrated Prevention and Treatment Services to People Who Use Drugs Where They Live | NIH | National Institute on Drug Abuse | 2022 to 2025 | $4,857,421 | June 15, 2022 | May 31, 2027 | SPRINGER, SANDRA ANN | reporter.nih.gov |
| HIV-1 Fusion Peptide-directed Vaccine Design Using Virus-like Particles | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,825,382 | March 1, 2021 | February 28, 2027 | KONG, RUI | reporter.nih.gov |
| Training in Biomedical Informatics at Columbia University | NIH | National Library of Medicine | 2021 to 2025 | $4,801,549 | July 1, 1992 | June 30, 2027 | ELHADAD, NOEMIE | reporter.nih.gov |
| Novel Stem Cell Immunotherapy for MDR-Tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,800,190 | June 4, 2021 | May 31, 2026 | JAGANNATH, CHINNASWAMY | reporter.nih.gov |
| Unmasking the roles of viral glycoproteins in oral transmission of KSHV | NIH | National Cancer Institute | 2021 to 2025 | $4,786,354 | September 1, 2021 | August 31, 2026 | OGEMBO, JAVIER GORDON | reporter.nih.gov |
| HOPE in Action: A clinical trial of HIV-to-HIV deceased donor kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $4,782,581 | August 31, 2021 | July 31, 2023 | DURAND, CHRISTINE MARIE | reporter.nih.gov |
| Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II) | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $4,760,584 | September 23, 2025 | August 31, 2030 | NAHID, PAYAM | reporter.nih.gov |
| Durable HIV Vaccine Targeting Mucosal Epithelium | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,751,308 | August 1, 2022 | July 31, 2027 | GAUDUIN, MARIE-CLAIRE ELISABETH | reporter.nih.gov |
| Sorting and Sequencing Latent Reservoirs in HIV+ Opioid Users | NIH | National Institute on Drug Abuse | 2023 to 2025 | $4,748,827 | September 15, 2023 | July 31, 2028 | OTT, MELANIE MARIA | reporter.nih.gov |
| Single Chromatin Fiber Sequencing and Longitudinal Epigenomic Profiling in HIV+ Brain Cells Exposed to Narcotic and Stimulant | NIH | National Institute on Drug Abuse | 2022 to 2025 | $4,732,000 | April 1, 2022 | February 28, 2027 | AKBARIAN, SCHAHRAM | reporter.nih.gov |
| PRESCIENT: A phase IIc, open-label, randomized controlled trial of ultra-short course bedaquiline, clofazimine, pyrazinamide and delamanid versus standard therapy for drug-susceptible tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,716,636 | May 1, 2025 | April 30, 2027 | KOENIG, SERENA PATRICIA | reporter.nih.gov |
| Immunologic control of HIV-1 through combination bNAbs and biologics. | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $4,702,057 | July 5, 2019 | December 31, 2025 | CASKEY, MARINA | reporter.nih.gov |
| Leveraging novel pediatric SHIVs to identify biomarkers of prophylactic efficacy of bnAb against breast milk HIV transmission | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $4,686,370 | September 25, 2025 | August 31, 2029 | FOUDA AMOU OU, GENEVIEVE GINY | reporter.nih.gov |
| Mechanisms of innate immune dysfunction in SIV/malaria co-infection in pregnancy | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $4,672,308 | September 24, 2021 | July 31, 2026 | MANUZAK, JENNIFER | reporter.nih.gov |
| Novel macrophage-tropic transmitted/founder SHIV model of CNS persistence to evaluate CRISPR/Cas9 gene editing | NIH | National Institute of Mental Health | 2021 to 2025 | $4,668,329 | July 5, 2021 | April 30, 2027 | BAR, KATHARINE JUNE | reporter.nih.gov |
| Integrating Addiction and Infectious Diseases Services into Primary Care in Rural Settings | NIH | National Institute on Drug Abuse | 2021 to 2025 | $4,664,222 | August 1, 2021 | May 31, 2027 | ALTICE, FREDERICK LEWIS | reporter.nih.gov |
| Population genotyping of the germline immunoglobulin repertoire in AIDS-designated rhesus macaque breeding colonies | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,657,141 | May 1, 2021 | August 31, 2030 | BOSINGER, STEVEN EDWARD | reporter.nih.gov |
| Single nucleus gene expression in moderate and compulsive drug self-administration in a rodent model of HIV | NIH | National Institute on Drug Abuse | 2022 to 2025 | $4,653,858 | March 15, 2022 | November 30, 2026 | SANNA, PIETRO P | reporter.nih.gov |
| Clinical Trial Site Monitoring for PHOENIx MDR-TB | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,653,435 | April 15, 2025 | December 14, 2025 | SMITH, KIMBERLY | reporter.nih.gov |
| The UNC/Emory Center for Innovative Technology (iTech) across the prevention and care continuum | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $4,640,955 | September 30, 2016 | November 30, 2022 | HIGHTOW-WEIDMAN, LISA B | reporter.nih.gov |
| Elicitation of HIV Broadly Neutralizing Antibodies from Engineered B cells | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,634,490 | July 1, 2021 | December 31, 2026 | VOSS, JAMES EVEN | reporter.nih.gov |
| MYCOBACTERIUM TUBERCULOSIS (MTB) QUALITY ASSESSMENT PROGRAM (TBQA) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $4,608,548 | January 1, 2023 | December 31, 2023 | COFFIN, JEANETTE | reporter.nih.gov |
| HIV-2 latency and its reversal | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,588,572 | September 20, 2021 | August 31, 2026 | TSIBRIS, ATHE M. | reporter.nih.gov |
| The CHARMED model: a multimorbidity simulation model for people aging with HIV | NIH | National Institute on Aging | 2021 to 2025 | $4,557,763 | April 1, 2021 | March 31, 2027 | HYLE, EMILY PARKER | reporter.nih.gov |
| Antiviral role of CD8+T cells in ART-treated SIV-infected macaques | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,522,689 | February 15, 2016 | March 31, 2027 | SILVESTRI, GUIDO | reporter.nih.gov |
| Optimizing HIV prevention for highly vulnerable methamphetamine-using sexual minority men | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $4,518,889 | April 8, 2022 | April 30, 2024 | GROV, CHRISTIAN | reporter.nih.gov |
| Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,508,465 | July 1, 2023 | June 30, 2028 | SEKALY, RAFICK PIERRE | reporter.nih.gov |
| Enhanced latency reversal and reservoir clearance in macaques | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,494,806 | June 23, 2021 | May 31, 2026 | CHAHROUDI, ANN M | reporter.nih.gov |
| HIV Reservoir Ecology of Viral Remission (PTC) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,488,119 | January 7, 2020 | August 31, 2030 | LI, JONATHAN | reporter.nih.gov |
| Impact of tuberculosis on the development and function of the immune system in SIV-infected infants | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $4,476,086 | April 1, 2019 | March 31, 2025 | WANG, XIAOLEI | reporter.nih.gov |
| Ultra-long Acting Transcutaneously Refillable Islatravir Nanofluidic Implant for HIV Pre-Exposure | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,459,174 | June 1, 2022 | May 31, 2027 | GRATTONI, ALESSANDRO | reporter.nih.gov |
| Rapid disease progression and viral reservoir formation in SIV-infected infant macaques | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,447,199 | June 15, 2021 | May 31, 2026 | SODORA, DONALD L | reporter.nih.gov |
| Maximizing germinal centers and somatic hypermutation to HIV Env immunogens | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,431,323 | February 1, 2016 | January 31, 2026 | CROTTY, SHANE P | reporter.nih.gov |
| Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,417,924 | June 3, 2022 | May 31, 2027 | GOLDSTEIN, HARRIS | reporter.nih.gov |
| A nonhuman primate model of stem cell transplantation to understand determinants of post-transplant SIV clearance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,411,202 | December 21, 2016 | June 30, 2026 | SACHA, JONAH B. | reporter.nih.gov |
| RNA binding and packaging by retroviral Gag proteins | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,401,848 | March 17, 2020 | June 30, 2029 | MUSIER-FORSYTH, KARIN M | reporter.nih.gov |
| Dissecting Polyclonal Sera to Reveal Correlates of Productive Immune Responses to HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,391,888 | March 16, 2018 | February 29, 2028 | WARD, ANDREW BARRETT | reporter.nih.gov |
| Impact of a novel HIV peer navigationand overdose prevention intervention on engagement in the HIV prevention and treatment cascade. | NIH | National Institute on Drug Abuse | 2021 to 2025 | $4,391,293 | September 1, 2021 | June 30, 2027 | SHERMAN, SUSAN G. | reporter.nih.gov |
| Patterns and predictors of viral suppression: A Big Data approach | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,380,945 | June 9, 2021 | May 31, 2027 | OLATOSI, BANKOLE | reporter.nih.gov |
| Multilevel strategies to understand and modify the role of structural and environmental context on HIV inequities for sexual and gender minorities of color | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $4,361,269 | March 18, 2022 | May 3, 2024 | RENDINA, H. JONATHON | reporter.nih.gov |
| HIV and musculoskeletal frailty: implications for care, policy and research | NIH | National Institute of Nursing Research | 2022 to 2025 | $4,358,664 | August 18, 2022 | May 31, 2027 | LOSINA, ELENA | reporter.nih.gov |
| MR-guided focused ultrasound to eradicate CNS viral reservoirs and promote neurogenesis in the HIV-infected brain | NIH | National Institute on Drug Abuse | 2021 to 2025 | $4,326,000 | June 1, 2021 | April 30, 2027 | CHANG, LINDA | reporter.nih.gov |
| Translational Studies of Cannabis Administration, Cognition, and the Endocannabinoid System in HIV | NIH | National Institute on Drug Abuse | 2021 to 2025 | $4,324,439 | May 1, 2021 | July 31, 2026 | MINASSIAN, ARPI | reporter.nih.gov |
| Study of HIV Infection in the Etiology of Lung Disease (SHIELD) AIR: Air Pollution Impact on Respiratory Health in HIV | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $4,320,983 | August 20, 2020 | July 31, 2025 | MCCORMACK, MEREDITH C | reporter.nih.gov |
| Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,313,524 | July 15, 2021 | June 30, 2027 | BAUM, MARC MICHAEL | reporter.nih.gov |
| Single nuclei transcriptome profiling in addiction circuitry of the HIV+ brain | NIH | National Institute on Drug Abuse | 2021 to 2025 | $4,310,228 | April 1, 2021 | February 28, 2027 | AKBARIAN, SCHAHRAM | reporter.nih.gov |
| Optimizing glycan shield coverage, germline B cell receptor binding and epitope diversity of V2-apex targeted HIV-1 Env immunogens | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,308,687 | September 19, 2019 | August 31, 2029 | HAHN, BEATRICE H | reporter.nih.gov |
| Tracking HIV Infection & Alcohol Abuse CNS Comorbidity with Neuroimaging | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $4,308,486 | September 30, 2007 | August 31, 2028 | PFEFFERBAUM, ADOLF | reporter.nih.gov |
| Structure-function studies of the membrane-interacting domains of HIV-1 Env spike | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,299,010 | May 20, 2016 | June 30, 2027 | CHEN, BING | reporter.nih.gov |
| LA HIV Treatment in Pediatrics | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $4,291,265 | March 15, 2020 | February 28, 2025 | JOHNSON, LEAH | reporter.nih.gov |
| Exploring, Predicting, and Intervening on Long-term Viral suppression Electronically (EPI-LoVE) | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $4,274,201 | May 3, 2023 | April 30, 2026 | GORBACH, PAMINA MAE | reporter.nih.gov |
| Combining germline-targeting, B cell immunofocusing and Env-Ab co-evolution strategies to induce HIV Envelope V2-apex broadly neutralizing antibodies | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $4,257,922 | April 1, 2021 | June 30, 2023 | ANDRABI, RAIEES AHMAD | reporter.nih.gov |
| Targeting HIV reservoirs in children with HIVIS DNA and MVA-CMDR vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,251,563 | February 1, 2018 | February 28, 2026 | ROBB, MERLIN L | reporter.nih.gov |
| Inflammation and Fibrosis in Pulmonary TB: the INFIN-TB Study | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,248,593 | July 1, 2025 | June 30, 2027 | AULD, SARA | reporter.nih.gov |
| Preventing TB with intravenous BCG in SIV-infected macaques | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,248,442 | May 5, 2021 | April 30, 2026 | SCANGA, CHARLES A. | reporter.nih.gov |
| Staged Low-Barrier and Mobile Care to Improve Retention and Viral Suppression in Hard-To-Reach Vulnerable People Living With HIV | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,238,983 | July 12, 2022 | June 30, 2027 | CHRISTOPOULOS, KATERINA A | reporter.nih.gov |
| Comprehensive Characterization of the T-cell Response to KSHV to Enable Specific Immune Therapy | NIH | National Cancer Institute | 2025 | $4,234,248 | September 19, 2025 | August 31, 2029 | WARREN, EDUS HOUSTON | reporter.nih.gov |
| AWARENESS, EDUCATION, AND TRAINING: CANCER TRIALS SUPPORT UNIT (CTSU) | NIH | National Cancer Institute | 2022 to 2025 | $4,229,641 | August 1, 2022 | July 31, 2025 | REED, CRYSTAL | reporter.nih.gov |
| RAPID ACCELERATION OF DIAGNOSTICS AWARD MANAGEMENT - HIV WP2 AWARDS | NIH | National Heart, Lung, and Blood Institute | 2025 | $4,221,341 | September 26, 2025 | September 25, 2027 | NEAL, REBEKAH | reporter.nih.gov |
| The Long-Acting/Extended Release Antiretroviral Resource Program (LEAP) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,204,220 | May 15, 2015 | June 30, 2030 | FLEXNER, CHARLES W. | reporter.nih.gov |
| Capturing spatial patterns of new M. tuberculosis infection in Kampala, Uganda | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,188,624 | August 9, 2019 | July 31, 2026 | BARK, CHARLES MARTYN | reporter.nih.gov |
| Integrating HCV services into HIV programs for PWID in India | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,184,487 | July 8, 2019 | June 30, 2025 | MEHTA, SHRUTI H | reporter.nih.gov |
| Promoting HIV risk reduction among people who inject drugs: A stepped care approach using contingency management with PrEP navigation | NIH | National Institute on Drug Abuse | 2021 to 2025 | $4,159,587 | July 1, 2020 | May 31, 2027 | EDELMAN, E. JENNIFER | reporter.nih.gov |
| SPPACE INSTI Study: Sex-specific Predictors, Pathways, And Cardiometabolic Effects of Weight Gain Associated with Integrase Strand-Transfer Inhibitors | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,154,622 | March 2, 2021 | February 28, 2027 | LAHIRI, CECILE DELILLE | reporter.nih.gov |
| Centralized Resource to Accurately Quantify Latent and Expressed HIV Reservoirs | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,143,400 | April 13, 2020 | March 31, 2025 | LAIRD, GREGORY MICHAEL | reporter.nih.gov |
| Inducing HIV-1 NAb Breadth by Native Trimer Prime-Boost Vaccination | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,133,062 | March 1, 2011 | May 31, 2025 | BINLEY, JAMES M | reporter.nih.gov |
| Optimizing HIV Care in Less Developed Countries | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,131,609 | August 1, 2023 | July 31, 2028 | FREEDBERG, KENNETH ALAN | reporter.nih.gov |
| Longitudinal Study of HIV and Aging in Brazil | NIH | National Institute on Aging | 2021 to 2025 | $4,122,466 | August 15, 2021 | April 30, 2027 | CASTILHO, JESSICA L | reporter.nih.gov |
| Pharmacogenomics of HIV Therapy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,091,190 | July 8, 2008 | March 31, 2027 | HAAS, DAVID W | reporter.nih.gov |
| Integrating the Visualization and Use of Stigma Data to Maximize the Impact of the Ending the HIV Epidemic Initiative | NIH | National Institute of Mental Health | 2022 to 2025 | $4,090,422 | July 8, 2022 | May 31, 2027 | BARAL, STEFAN DAVID | reporter.nih.gov |
| Cytomegalovirus (CMV), the gut barrier and immune dysfunction in HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,077,185 | March 15, 2021 | February 28, 2027 | SHACKLETT, BARBARA L. | reporter.nih.gov |
| Childhood Omics and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $4,076,080 | April 22, 2020 | August 31, 2025 | CATTAMANCHI, ADITHYA | reporter.nih.gov |
| Characterizing the viral and host effector mechanisms that govern HIV-1 rebound | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,062,283 | June 25, 2021 | May 31, 2027 | BAR, KATHARINE JUNE | reporter.nih.gov |
| NextGen Long-acting and targeted combination ART for Children with HIV | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,058,459 | April 6, 2020 | March 31, 2027 | HO, RODNEY J.Y. | reporter.nih.gov |
| Integrating tobacco use cessation into HIV Care and Treatment in Ministry of Health Facilities in Kisumu County, Kenya | NIH | National Cancer Institute | 2021 to 2025 | $4,048,603 | September 16, 2021 | August 31, 2026 | BIALOUS, STELLA AGUINAGA | reporter.nih.gov |
| CAMELLIA Cohort: A longitudinal study to understand sexual health and prevention among women in Alabama | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $4,046,847 | September 8, 2022 | August 31, 2027 | RANA, AADIA | reporter.nih.gov |
| Understanding Viral Suppression for Newly Diagnosed HIV+ Men to Inform Implementation of TasP and U=U | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,045,904 | March 24, 2020 | February 28, 2027 | RYBICKI-NEWMAN, MARIA | reporter.nih.gov |
| Single nucleus gene expression in moderate and compulsive opioid self-administration in a rodent model of HIV | NIH | National Institute on Drug Abuse | 2023 to 2025 | $4,045,522 | September 1, 2023 | June 30, 2028 | SANNA, PIETRO P | reporter.nih.gov |
| Role of myeloid cells in CNS and systemic reservoirs and rebound | NIH | National Institute of Mental Health | 2022 to 2025 | $4,042,269 | January 1, 2022 | November 30, 2026 | HOPE, THOMAS | reporter.nih.gov |
| Integrative Single Cell isoform and chromatin accessibility Mapping of Chronic Opioid Exposure in Cognitive Brain Areas in HIV | NIH | National Institute on Drug Abuse | 2021 to 2025 | $4,038,720 | September 30, 2021 | June 30, 2027 | TILGNER, HAGEN ULRICH | reporter.nih.gov |
| (PQ3) Addressing Cancer Treatment Disparities for Persons with HIV | NIH | National Cancer Institute | 2021 to 2025 | $4,038,411 | June 15, 2021 | May 31, 2027 | SILVERBERG, MICHAEL J | reporter.nih.gov |
| A Comprehensive Community-based Strategy to Optimize the HIV Prevention and Treatment Continuum for Youth At HIV Risk, Acutely Infected and with Established HIV Infection | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $4,026,613 | September 30, 2016 | November 30, 2022 | SWENDEMAN, DALLAS TRAVIS | reporter.nih.gov |
| The HUSH complex in HIV-1 latency | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,024,795 | July 1, 2019 | May 31, 2029 | LUBAN, JEREMY | reporter.nih.gov |
| HIV-1 dynamics and evolution during trispecific broadly neutralizing antibody therapy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,008,532 | April 8, 2021 | March 31, 2026 | TSIBRIS, ATHE M. | reporter.nih.gov |
| Scaling Up Implementation Strategies to Improve the DIAGNOSE and PREVENT Pillars for Young MSM in Florida | NIH | National Institute of Mental Health | 2022 to 2025 | $4,004,279 | August 4, 2022 | May 31, 2027 | NAAR, SYLVIE | reporter.nih.gov |
| Expanded SPF breeding colony housing at the Emory National Primate Research Center | NIH | Office of the Director, National Institutes of Health | 2024 | $4,000,000 | September 15, 2024 | May 31, 2029 | COHEN, JOYCE KIMBERLY | reporter.nih.gov |
| Indoor-Outdoor Housing Expansion of the TNPRC SPF Macaque Breeding Colony to Support HIV/AIDS-related Research | NIH | Office of the Director, National Institutes of Health | 2025 | $3,999,180 | September 15, 2025 | May 31, 2028 | RUSSELL-LODRIGUE, KASI E | reporter.nih.gov |
| Expansion of Macaque Breeding runs at the New Iberia Research Center | NIH | Office of the Director, National Institutes of Health | 2023 | $3,999,070 | September 12, 2023 | August 31, 2027 | VILLINGER, FRANCOIS J | reporter.nih.gov |
| SPF Rhesus Macaque Breeding Colony Expansion to Support HIV/AIDS-Related Research | NIH | Office of the Director, National Institutes of Health | 2024 | $3,999,041 | September 17, 2024 | May 31, 2029 | RUSSELL-LODRIGUE, KASI E | reporter.nih.gov |
| Controlled Trial of Game Changers: A Group Intervention to Train HIV Clients to be Change Agents for HIV Prevention in Uganda | NIH | National Institute of Mental Health | 2021 to 2025 | $3,990,796 | July 6, 2021 | May 31, 2027 | WAGNER, GLENN JOHN | reporter.nih.gov |
| Rational Systemic Characterization and Selection of Adjuvants for HIV Vaccine Candidates (R-CASA) | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $3,983,710 | August 1, 2025 | July 31, 2026 | CHATTERJEE, ARNAB KUMAR | reporter.nih.gov |
| Innovative Network on the Science and Practice of Implementation, Research, and Engagement Center (INSPIRE) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $3,975,076 | September 13, 2024 | July 31, 2028 | IWELUNMOR, JULIET | reporter.nih.gov |
| Adolescent-tailored HIV treatment and prevention strategies in South Africa: projecting clinical benefits and value | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $3,967,474 | September 20, 2022 | August 31, 2027 | NEILAN, ANNE | reporter.nih.gov |
| Characterizing Sleep, ART Adherence and Viral Suppression | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,926,963 | September 15, 2021 | July 31, 2027 | DUNCAN, DUSTIN T | reporter.nih.gov |
| Characterizing the role of social, behavioral, and economic stigmas as determinants of HIV and mental health across the US | NIH | National Institute of Nursing Research | 2021 to 2025 | $3,922,514 | September 22, 2021 | June 30, 2027 | BARAL, STEFAN DAVID | reporter.nih.gov |
| Effect of estrogen replacement on postmenopausal ART-associated comorbidity and viral latency | NIH | National Institute on Aging | 2021 to 2025 | $3,922,003 | August 15, 2021 | April 30, 2026 | KIEVIT, PAUL | reporter.nih.gov |
| HIV Drug Resistance Database | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,908,327 | May 1, 2018 | April 30, 2028 | SHAFER, ROBERT WILLIAM | reporter.nih.gov |
| Tracking the evolutionary trajectory of neutralizing antibodies following BG505 SOSIP immunization | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,907,608 | June 16, 2023 | May 31, 2027 | DERDEYN, CYNTHIA ANN | reporter.nih.gov |
| Understanding Co-morbidities: COVID-19 in individuals living with HIV/AIDS | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,900,756 | February 1, 2022 | January 31, 2027 | SINGH, DHIRAJ KUMAR | reporter.nih.gov |
| Trial of Human Milk Oligosaccharide-based synbiotics for HIV-exposed uninfected children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,899,337 | June 1, 2021 | May 31, 2027 | SHIVAKOTI, RUPAK | reporter.nih.gov |
| Intensive Combination Approach to Rollback the HIV Epidemic in Nigerian Youth (iCARE) Plus Effectiveness / Implementation Hybrid Study | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $3,898,240 | September 8, 2023 | January 5, 2029 | GAROFALO, ROBERT | reporter.nih.gov |
| Influence of HIV infection on vaginal virome and risk of preterm birth in pregnant South African women | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,895,544 | September 9, 2021 | July 31, 2027 | JASPAN, HEATHER BERYL | reporter.nih.gov |
| Development of multi-modal single-cell technology to dissect epitope specificity to HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,892,813 | June 26, 2015 | May 31, 2026 | BOSINGER, STEVEN EDWARD | reporter.nih.gov |
| Research Training in Biomedical Informatics and Data Science at Oregon Health & Science University | NIH | National Library of Medicine | 2021 to 2025 | $3,887,592 | July 1, 1992 | June 30, 2027 | MOHAN, VISHNU | reporter.nih.gov |
| Comprehensive, tailored, technology-based intervention to improve virologic suppression among youth and young adults living with HIV | NIH | National Institute of Mental Health | 2022 to 2025 | $3,886,971 | September 1, 2022 | June 30, 2027 | SABERI, PARYA | reporter.nih.gov |
| HIV Persistence and Renewal in the Gastrointestinal, Genitourinary and Adipose Tissues | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,879,562 | September 17, 2021 | July 31, 2026 | SMITH, DAVID MITCHELL | reporter.nih.gov |
| Structure-Based Antagonism of HIV-1 Envelope Function in Cell Entry | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $3,877,325 | August 1, 1997 | August 31, 2024 | CHAIKEN, IRWIN M | reporter.nih.gov |
| Cluster Randomized Controlled Trial of Using PrEP Doing it for Ourselves Protective Styles: A Multilevel Intervention to Improve HIV Testing and PrEP Uptake among Southeastern US at-risk populations | NIH | National Institute of Nursing Research | 2024 to 2025 | $3,870,187 | August 9, 2024 | May 31, 2029 | RANDOLPH, SCHENITA D. | reporter.nih.gov |
| Structural definition of CD4-induced HIV-1 Env conformational changes required for infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,868,455 | February 1, 2019 | July 31, 2030 | ACHARYA, PRIYAMVADA | reporter.nih.gov |
| Making Better Decisions: Policy Modeling for AIDS and Drug Abuse | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,865,844 | September 25, 2022 | January 31, 2029 | OWENS, DOUGLAS K | reporter.nih.gov |
| Phase 2 Study of the Efficacy and Safety of ORC-13661 for the Prevention of Ototoxicity in Patients Receiving Intravenous Amikacin for Treatment of Non-Tuberculous Mycobacterium Infection | NIH | National Institute on Deafness and Other Communication Disorders | 2022 to 2025 | $3,863,432 | September 19, 2022 | July 31, 2027 | WINTHROP, KEVIN LORING | reporter.nih.gov |
| Effects of HIV and ART on myelination in the adolescent | NIH | National Institute of Mental Health | 2021 to 2025 | $3,855,807 | April 1, 2021 | January 31, 2027 | JORDAN-SCIUTTO, KELLY L | reporter.nih.gov |
| Induction of autophagy to enhance CAR-T cells in HIV cure approaches | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,855,196 | June 25, 2022 | May 31, 2027 | ZHEN, ANJIE | reporter.nih.gov |
| A Solid-Phase, Long-Acting CCR5 Monoclonal Antibody for HIV Transmission | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,844,108 | July 23, 2020 | June 30, 2025 | SACHA, JONAH B. | reporter.nih.gov |
| At the Intersection of HIV and COVID-19: Medicaid Data as a Complement to Cohort Studies | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,843,434 | June 10, 2022 | May 31, 2027 | LAU, BRYAN | reporter.nih.gov |
| A Rhesus Macaque Model of HIV and HBV co-infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,842,980 | March 20, 2021 | February 28, 2026 | BURWITZ, BENJAMIN J | reporter.nih.gov |
| A Gene Drive Therapy for HIV: single-administration intervention for high-risk groups | NIH | National Institute on Drug Abuse | 2021 to 2024 | $3,842,823 | April 15, 2020 | August 31, 2024 | WEINBERGER, LEOR S | reporter.nih.gov |
| Molecular mechanisms underlying HIV related intestinal epithelial barrier dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,842,606 | August 1, 2021 | December 31, 2026 | PARKOS, CHARLES A | reporter.nih.gov |
| The Effectiveness of Automated Multimodal Imaging in High Grade Squamous Intraepithelial Lesions (HSIL) Diagnosis for People Living with HIV: An International Trial | NIH | National Cancer Institute | 2021 to 2025 | $3,831,300 | December 18, 2018 | August 31, 2029 | ANANDASABAPATHY, SHARMILA | reporter.nih.gov |
| A novel REverSe Transcriptase Chain Termination (RESTRICT) assay for near-patient, objective monitoring of long-term PrEP adherence | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,828,468 | November 9, 2020 | October 31, 2026 | DRAIN, PAUL K | reporter.nih.gov |
| Immune Dysfunction in HIV+ Opioid Users | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,823,539 | April 15, 2020 | January 31, 2027 | PAHWA, SAVITA | reporter.nih.gov |
| PET IMAGING OF SYNAPTIC DENSITY COMBINED WITH NEUROIMMUNOLOGIC MEASURES TO REVEAL MECHANISMS OF HIV NEUROPATHOGENESIS DURING ART | NIH | National Institute of Mental Health | 2021 to 2024 | $3,822,784 | September 15, 2020 | July 31, 2025 | SPUDICH, SERENA S | reporter.nih.gov |
| HIV Genomic Aging Project in Oncology (HIV-GAP) | NIH | National Cancer Institute | 2021 to 2025 | $3,820,924 | September 20, 2021 | August 31, 2027 | COGHILL, ANNA | reporter.nih.gov |
| Statistical Issues in AIDS Research | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,816,097 | September 30, 1989 | March 31, 2029 | HUGHES, JAMES P | reporter.nih.gov |
| Harnessing adaptive NK cell transfer to deplete viral reservoirs | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,812,634 | April 16, 2021 | March 31, 2027 | EVANS, DAVID T | reporter.nih.gov |
| Strategic antiretroviral therapy and HIV testing for youth in rural Africa | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $3,809,938 | September 1, 2018 | August 31, 2025 | HAVLIR, DIANE V | reporter.nih.gov |
| Acceptable Multi-user Biodegradable Extended Release (AMBER) Implant System for HIV Prevention | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,802,403 | August 20, 2020 | July 31, 2025 | JOHNSON, LEAH | reporter.nih.gov |
| MyPEEPS Mobile LITE: Limited Interaction Efficacy Trial of MyPEEPS Mobile to Reduce HIV Incidence and Better Understand the Epidemiology of HIV among YMSM | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $3,798,069 | September 1, 2022 | June 30, 2024 | SCHNALL, REBECCA | reporter.nih.gov |
| Natural killer cell engineering to target the HIV reservoir | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,790,684 | April 1, 2021 | March 31, 2026 | ZACK, JEROME A. | reporter.nih.gov |
| Expanding the potential of couples HIV testing: Adjunct modules to reduce drug use among vulnerable male couples | NIH | National Institute on Drug Abuse | 2021 to 2024 | $3,790,611 | July 15, 2020 | May 31, 2026 | STARKS, TYREL J | reporter.nih.gov |
| Heavy cannabis use, neurocognition and PrEP care engagement among young Black sexual minority men | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,790,453 | September 15, 2022 | June 30, 2027 | SCHNEIDER, JOHN | reporter.nih.gov |
| Point-of-care C-reactive protein-based tuberculosis screening in people living with HIV: a randomized trial | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,789,374 | September 15, 2019 | May 31, 2025 | YOON, CHRISTINA | reporter.nih.gov |
| Activated NK CAR Cells to Cure HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,780,061 | April 2, 2021 | March 31, 2027 | SKINNER, PAMELA J | reporter.nih.gov |
| Immune response to COVID-19 vaccine in HIV infected men and women | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,779,701 | September 23, 2021 | August 31, 2026 | RINALDO, CHARLES R | reporter.nih.gov |
| Commensal microbiome impact on CD4 T cell lymphopenia in HIV-1 infection | NIH | National Institute on Aging | 2022 to 2025 | $3,776,712 | September 15, 2022 | May 31, 2027 | YOUNES, SOUHEIL ANTOINE | reporter.nih.gov |
| Characterizing the mechanism of post-treatment control of SIV in Mauritian cynomolgus macaques | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,772,603 | December 5, 2013 | April 30, 2029 | OCONNOR, SHELBY L | reporter.nih.gov |
| Effect of buprenorphine on monocytes in the context of neuroAids and opioid abuse | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,772,066 | April 15, 2017 | July 31, 2027 | BERMAN, JOAN WEINBERGER | reporter.nih.gov |
| A relationship-focused intervention to reduce intimate partner violence and increase PrEP uptake and adherence among adolescent girls and young women in Kenya | NIH | National Institute of Mental Health | 2021 to 2025 | $3,768,144 | August 19, 2021 | July 31, 2027 | ROBERTS, SARAH TYLER | reporter.nih.gov |
| Optimization of a behavioral intervention to increase physical activity in older adults living with HIV | NIH | National Institute on Aging | 2022 to 2025 | $3,763,771 | September 1, 2022 | August 31, 2027 | UEBELACKER, LISA A | reporter.nih.gov |
| Role of ncRNA Surveillance Complex "RNA Exosome" in Class Switch Recombination and Somatic Hypermutation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,761,466 | May 7, 2012 | April 30, 2027 | BASU, UTTIYA | reporter.nih.gov |
| Spatio-temporal Methods for Surveillance of the Opioid Syndemic | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,748,657 | September 1, 2025 | August 31, 2029 | KLINE, DAVID M | reporter.nih.gov |
| Modeling HIV Microglia-Associated Infection and Inflammation in a Chimeric Mouse Brain | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,747,870 | August 1, 2021 | May 31, 2027 | AKBARIAN, SCHAHRAM | reporter.nih.gov |
| Miami Dade County ASsessment of Phylogenetics to Improve Resource Equity: MD ASPIRE | NIH | National Institute of Mental Health | 2022 to 2025 | $3,746,850 | July 1, 2022 | April 30, 2027 | LITTLE, SUSAN JANET | reporter.nih.gov |
| Biomarker-Based Diagnostic Algorithms To Prevent, Detect And Guide Treatment Of Kidney Disease In Persons Living With HIV | NIH | National Institute on Aging | 2021 to 2025 | $3,746,708 | September 1, 2010 | May 31, 2027 | SHLIPAK, MICHAEL G | reporter.nih.gov |
| Multi-OMICS identification and validation of mechanisms triggered by Immune interventions aimed at reducing the size of the replication competent Reservoir | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,741,426 | July 3, 2023 | April 30, 2028 | SEKALY, RAFICK PIERRE | reporter.nih.gov |
| Ultra-Long-Acting Polymeric Injectable Multi-Purpose Prevention Technology for Contraception and HIV Prevention | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,740,241 | April 13, 2021 | March 31, 2027 | BENHABBOUR, SOUMYA RAHIMA | reporter.nih.gov |
| AmbassADDOrs for Health: Supporting young women's health through girl-friendly drug vendors | NIH | National Institute of Mental Health | 2021 to 2025 | $3,737,819 | May 6, 2021 | March 31, 2026 | LIU, JENNY XIN | reporter.nih.gov |
| THE NIH NATIONAL NEUROHIV TISSUE CONSORTIUM (NNTC) - NEW CLINICAL SITE | NIH | National Institute of Mental Health | 2024 to 2025 | $3,736,455 | September 23, 2024 | September 22, 2026 | ANCES, BEAU M | reporter.nih.gov |
| Bacteria and Host in TB Transmission | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $3,731,271 | April 10, 2020 | March 31, 2023 | ALLAND, DAVID | reporter.nih.gov |
| Cannabis and Pathogenic Mechanisms influencing Blood Brain Barrier Function in HIV | NIH | National Institute on Drug Abuse | 2023 to 2025 | $3,726,178 | August 15, 2023 | June 30, 2028 | IUDICELLO, JENNIFER E | reporter.nih.gov |
| Making women's options for HIV prevention in Tanzania accessible and joining implementation science capacity building (MWOTAJI) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $3,724,768 | September 18, 2023 | August 31, 2028 | ANASEL, MACKFALLEN GILIADI | reporter.nih.gov |
| Efficacy of a PrEP uptake & Adherence Intervention among male sex workers using a 2-stage randomization design | NIH | National Institute of Nursing Research | 2021 to 2025 | $3,717,256 | July 8, 2021 | March 31, 2027 | BIELLO, KATIE BROOKS | reporter.nih.gov |
| Single-Cell Analysis of the HIV/SIV Reservoir | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,716,718 | June 10, 2020 | May 31, 2026 | BAROUCH, DAN H. | reporter.nih.gov |
| Improving Diagnosis, Treatment & Detection of Drug Resistance in HIV-2 Infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,714,082 | June 15, 2015 | August 31, 2030 | GOTTLIEB, GEOFFREY SCOTT | reporter.nih.gov |
| "Corral and Kill" strategy for HIV eradication using MSC in an SIV model | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,712,736 | March 23, 2020 | February 28, 2030 | DANDEKAR, SATYA | reporter.nih.gov |
| Production of cGMP Native Flexibly Linked HIV-1 Envelope Protein | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,709,483 | September 12, 2016 | March 31, 2028 | FOUTS, TIMOTHY | reporter.nih.gov |
| Persistent HIV-1 expression and microglia dysfunction | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,708,561 | August 1, 2021 | May 31, 2027 | HENDERSON, ANDREW J | reporter.nih.gov |
| Development and Validation of a Novel and HIV-Relevant Prediction Model for Fracture | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,707,719 | April 1, 2021 | March 31, 2027 | HSIEH, EVELYN | reporter.nih.gov |
| Conduct Synthesis and Acquire Batches of Compounds for Subsequent Biological In Vitro and In Vivo Testing | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,702,250 | April 1, 2024 | March 31, 2025 | MIDDLETON, MARK | reporter.nih.gov |
| Exploiting antibody catalysis for treating Cryptococcosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,699,200 | May 25, 2021 | April 30, 2027 | CASADEVALL, ARTURO | reporter.nih.gov |
| Nonhuman Primate Core Virology Laboratory for AIDS Vaccine Research and Development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,695,898 | December 22, 2017 | December 14, 2024 | DENNY, THOMAS | reporter.nih.gov |
| Combined cytokine therapy for sustained HIV remission | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,695,050 | March 17, 2020 | February 28, 2026 | VELU, VIJAYAKUMAR | reporter.nih.gov |
| Mtb and HIV/SIV antigen peptide signatures as blood biomarkers to detect early infection to active disease in young children and NHP | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,693,137 | May 1, 2021 | March 31, 2027 | LYON, CHRISTOPHER J | reporter.nih.gov |
| Cost-Effectiveness of Preventing HIV Complications | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,680,074 | April 1, 1998 | July 31, 2026 | FREEDBERG, KENNETH ALAN | reporter.nih.gov |
| Defining sex-based differences in the replication-competent myeloid reservoir in virally suppressed people with HIV and SIV-infected ART-suppressed macaques | NIH | National Institute of Mental Health | 2021 to 2025 | $3,672,918 | July 15, 2021 | May 31, 2027 | VEENHUIS, REBECCA TERILLI | reporter.nih.gov |
| 2/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,669,568 | September 17, 2021 | August 31, 2026 | SPINO, CATHERINE A | reporter.nih.gov |
| Using immune complex vaccines to optimize antibody responses to HIV Env | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,657,831 | March 12, 2020 | February 28, 2027 | HIOE, CATARINA E | reporter.nih.gov |
| NMR Studies of Retroviral Nucleic Acid Binding Proteins | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,656,208 | July 1, 1989 | December 31, 2027 | SUMMERS, MICHAEL FINLEY | reporter.nih.gov |
| Biopsychosocial Phenotypes and Potential Mechanisms in CHARTER | NIH | National Institute of Mental Health | 2021 to 2025 | $3,655,824 | December 8, 2020 | October 31, 2026 | LETENDRE, SCOTT L | reporter.nih.gov |
| The Bring BPaL2Me Trial - Comparing Nurse-Led RR-TB Treatment in Primary Care to Physician-Led, Hospital-Based RR-TB Treatment: A Cluster Randomized, Non-Inferiority Trial | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,655,506 | March 10, 2023 | February 29, 2028 | FARLEY, JASON EDWARD | reporter.nih.gov |
| HIV/ART, low birth weight, and mortality in HIV-exposed uninfected children: a translational mechanistic study | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,646,054 | April 15, 2021 | March 31, 2027 | YOTEBIENG, MARCEL | reporter.nih.gov |
| Reconstructing HIV Epidemics from HIV Phylogenetics | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,645,566 | June 15, 2010 | August 31, 2025 | LEITNER, THOMAS K. | reporter.nih.gov |
| An Etonogestrel/Ethinyl Estradiol/QGriffithsin (ETG/EE/QGRFT) IVR to Prevent Pregnancy and HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,644,121 | April 6, 2020 | August 31, 2025 | TELESHOVA, NATALIA | reporter.nih.gov |
| Quantification of HIV burden and the biomedical, structural, and behavioral factors influencing HIV/AIDS among children and young adolescents | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,642,543 | March 5, 2021 | March 31, 2026 | KYU, HMWE HMWE | reporter.nih.gov |
| Effects of HIV SIV on unconventional T cells in immunity to M. tuberculosis in pre adolescents | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $3,631,144 | March 4, 2019 | February 28, 2025 | SCANGA, CHARLES A. | reporter.nih.gov |
| Novel pathogenic mechanism of HIV-associated CNS neurological disorders | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,625,378 | July 15, 2021 | May 31, 2027 | BUKRINSKY, MICHAEL ILYA | reporter.nih.gov |
| Cannabis use, PrEP and HIV transmission risk | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,624,329 | August 1, 2021 | May 31, 2027 | DUNCAN, DUSTIN T | reporter.nih.gov |
| Ultrasensitive HIV viral load quantitation using designer DNA nanostructure capture probes and photonic resonator interference scattering microscopy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,622,822 | January 21, 2021 | December 31, 2026 | DEMIRCI, UTKAN | reporter.nih.gov |
| Revealing the role of platelets in promoting HIV reservoir seeding and persistence in the CNS-resident myeloid cells | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,617,591 | August 15, 2021 | June 30, 2027 | MAGGIRWAR, SANJAY B. | reporter.nih.gov |
| Understanding Immune Evasion by HIV-1 Repliclones | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,617,103 | June 10, 2021 | May 31, 2027 | HALVAS, ELIAS K. | reporter.nih.gov |
| Targeting the NLRP3 Inflammasome to Mitigate Neuroinflammation and HIV Persistence in the CNS: Mechanisms and Therapeutic Strategies | NIH | National Institute of Mental Health | 2025 | $3,613,504 | September 22, 2025 | September 21, 2029 | SWARTZ, TALIA H | reporter.nih.gov |
| Targeting CNS reservoirs with CAR/CXCR5 T cells for the long-term remission of HIV | NIH | National Institute of Mental Health | 2022 to 2025 | $3,610,311 | August 5, 2022 | May 31, 2027 | SKINNER, PAMELA J | reporter.nih.gov |
| Innovation across the spectrum of pediatric HIV care: Clinical impact and cost-effectiveness of long-acting antiretroviral therapy for breastfeeding people with HIV and their infants in Zimbabwe | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $3,608,359 | July 1, 2014 | June 30, 2025 | CIARANELLO, ANDREA LYNNE | reporter.nih.gov |
| Optimizing AAV delivery of bNAbs for HIV prevention | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,607,044 | November 24, 2021 | October 31, 2026 | GARDNER, MATTHEW RYAN | reporter.nih.gov |
| Vanderbilt Biomedical Informatics Training Program | NIH | National Library of Medicine | 2021 to 2025 | $3,600,532 | July 1, 2002 | June 30, 2027 | ANCKER, JESSICA S. | reporter.nih.gov |
| Investigating Psychosocial Experiences of HIV Cure Trial Participants Undergoing Extended HIV Treatment Interruptions: Implications for Ethical Conduct | NIH | National Institute of Mental Health | 2021 to 2025 | $3,595,058 | September 1, 2021 | June 30, 2027 | SAUCEDA, JOHN ANDREW | reporter.nih.gov |
| Defining the impact of glycan-microdomains of the HIV-1 Env glycan shield | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,593,005 | April 10, 2021 | March 31, 2027 | RENFROW, MATTHEW B | reporter.nih.gov |
| HIV-1 Preintegration Trafficking and Nuclear Localization | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,586,576 | January 15, 2003 | May 31, 2027 | ENGELMAN, ALAN N. | reporter.nih.gov |
| Novel pre-coital, non-hormonal multipurpose prevention technology (MPT) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,585,858 | March 20, 2020 | February 28, 2026 | ANGSANTIKUL, PAVIMOL | reporter.nih.gov |
| Effects of Cannabidiol and Tetrahydrocannabinol on the Microbiome, Endocannabinoids and Neuroinflammation in HIV | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,584,464 | June 15, 2022 | March 31, 2027 | ELLIS, RONALD J. | reporter.nih.gov |
| Mechanisms of B cell responses to particulate antigens | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,582,696 | July 1, 2021 | June 30, 2027 | CHENG, WEI | reporter.nih.gov |
| Brain Myeloid Cells are Sources of HIV-associated Damage and Viral Dispersal | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,578,599 | July 15, 2021 | April 30, 2027 | CHAILLON, ANTOINE | reporter.nih.gov |
| ED2PrEP - patient focused, low-burden strategies for PrEP uptake among emergency departments patients: a cross-over hybrid implementation-effectiveness trial | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,577,090 | June 24, 2022 | March 21, 2025 | FELSEN, URIEL | reporter.nih.gov |
| Effects of CSF1R Blockade on Repopulation of SIV Reservoirs from the CNS to the Periphery After Antiretroviral Therapy Interruption | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,573,272 | July 15, 2021 | June 30, 2027 | WILLIAMS, KENNETH C | reporter.nih.gov |
| Immunometabolicgene expression profiles associated with depressed mood and behavioral domains inpeople with HIV | NIH | National Institute of Mental Health | 2021 to 2025 | $3,570,509 | September 15, 2021 | June 30, 2026 | ELLIS, RONALD J. | reporter.nih.gov |
| Individualized HIV Curative Combination Strategy against Persistent HIV on ART | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,568,644 | July 7, 2025 | May 31, 2030 | MONTANER, LUIS J | reporter.nih.gov |
| Predicting neurodevelopmental risk in children born to mothers living with HIV in Kenya | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,564,109 | April 9, 2021 | January 31, 2027 | MCHENRY, MEGAN SONG | reporter.nih.gov |
| Resilient HIV Implementation Science with Sexual and Gender Minority Youths using Evidence (RISE) Clinical Research Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $3,561,650 | September 1, 2023 | June 30, 2028 | CHARURAT, MANHATTAN E | reporter.nih.gov |
| Transforming HIV vaccine design with a hybrid technology that leverages features of mRNA and protein nanoparticle platforms | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,559,750 | September 26, 2025 | August 31, 2029 | HOFFMANN, MAGNUS ADRIAN GERO | reporter.nih.gov |
| A Bioresorbable Subdermal Implant for Sustained Delivery of a Novel Maturation Inhibitor to Prevent HIV Infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,558,948 | August 28, 2020 | July 31, 2025 | MOSS, JOHN A | reporter.nih.gov |
| Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma | NIH | National Cancer Institute | 2021 to 2023 | $3,557,045 | May 1, 2021 | April 30, 2024 | NIXON, DOUGLAS F | reporter.nih.gov |
| Violence and viral suppression among men living with HIV | NIH | National Institute of Mental Health | 2021 to 2025 | $3,556,062 | December 1, 2020 | December 30, 2026 | KAHLE, ERIN M | reporter.nih.gov |
| Assessing the effects of oral pre-exposure prophylaxis on pharmacokinetics of monoclonal and vaccine-induced antibodies among women vulnerable to HIV-1 | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,554,273 | September 12, 2025 | August 31, 2029 | HUANG, YUNDA | reporter.nih.gov |
| KIR and MHC Class I Immunogenetics in SIV Infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,547,833 | December 18, 2023 | October 31, 2028 | EVANS, DAVID T | reporter.nih.gov |
| Hodgkin Lymphoma in PLWH in South Africa: TB, EBV, and Tumor Molecular Markers | NIH | National Cancer Institute | 2021 to 2024 | $3,536,890 | April 1, 2020 | September 30, 2025 | AMBINDER, RICHARD FREDERICK | reporter.nih.gov |
| Biochemical Mechanism of HIV DNA Integration | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,536,253 | June 1, 2025 | May 31, 2030 | ENGELMAN, ALAN N. | reporter.nih.gov |
| Inter- and Intra-cellular effects of cannabinoids, HIV and ART in the CNS | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,529,874 | August 1, 2020 | May 31, 2027 | JORDAN-SCIUTTO, KELLY L | reporter.nih.gov |
| A type 2 hybrid effectiveness-implementation trial to evaluate a population health combination intervention to meet HIV testing, linkage, and viral suppression goals in coastal Alabama | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,529,673 | July 1, 2022 | June 30, 2027 | RANA, AADIA | reporter.nih.gov |
| Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing (S-ITEST) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $3,529,091 | January 24, 2024 | August 31, 2028 | IWELUNMOR, JULIET | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| University of California Los Angeles | Los Angeles, CA | 93 | $741.2 million | 0 | $0 |
| Fred Hutchinson Cancer Center | Seattle, WA | 53 | $731.2 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 261 | $692.1 million | 0 | $0 |
| PPD Development LP | Wilmington, NC | 4 | $689.7 million | 0 | $0 |
| Emory University | Atlanta, GA | 172 | $422 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 200 | $391.6 million | 0 | $0 |
| Duke University | Durham, NC | 95 | $347.6 million | 0 | $0 |
| University of Washington | Seattle, WA | 177 | $331.3 million | 0 | $0 |
| Harvard University D/b/a Harvard School of Public Health | Boston, MA | 21 | $310.6 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 136 | $284.1 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 113 | $257.9 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 40 | $247.5 million | 0 | $0 |
| Family Health International | Durham, NC | 3 | $215.6 million | 0 | $0 |
| Westat, Inc. | Bethesda, MD | 6 | $210.4 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 55 | $200.1 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 122 | $192.2 million | 0 | $0 |
| Yale University | New Haven, CT | 119 | $191.5 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 70 | $174.6 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 41 | $162.3 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 83 | $162.1 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 98 | $161 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 68 | $160.9 million | 0 | $0 |
| Tulane University of Louisiana | New Orleans, LA | 51 | $155.8 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 62 | $155.8 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 81 | $145.5 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 61 | $145.5 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 70 | $137.6 million | 0 | $0 |
| George Washington University | Washington, DC | 45 | $128.4 million | 0 | $0 |
| Seattle Children's Hospital | Seattle, WA | 21 | $125.2 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 67 | $118.2 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 37 | $115.2 million | 0 | $0 |
| University of California at Davis | Davis, CA | 22 | $99.9 million | 0 | $0 |
| Texas Biomedical Research Institute | San Antonio, TX | 27 | $98.1 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 51 | $95.8 million | 0 | $0 |
| Technical Resources International, Inc. | Bethesda, MD | 6 | $94.3 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 64 | $92 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 23 | $87.2 million | 0 | $0 |
| Ctis, Inc. | Rockville, MD | 1 | $86.9 million | 0 | $0 |
| Washington University | Saint Louis, MO | 60 | $86 million | 0 | $0 |
| National Opinion Research Center | Chicago, IL | 1 | $81.3 million | 0 | $0 |
| Fisher Bioservices, Inc. | Rockville, MD | 8 | $80.4 million | 0 | $0 |
| Wistar Institute | Philadelphia, PA | 21 | $79.5 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 57 | $77.6 million | 0 | $0 |
| University of Florida | Gainesville, FL | 64 | $70.1 million | 0 | $0 |
| University of TX MD Anderson Can CTR | Houston, TX | 6 | $68.6 million | 0 | $0 |
| J. David Gladstone Institutes | San Francisco, CA | 22 | $68.1 million | 0 | $0 |
| Research Triangle Institute | Research Triangle Park, NC | 26 | $64.8 million | 0 | $0 |
| Ohio State University | Columbus, OH | 36 | $62.9 million | 0 | $0 |
| University of Nebraska Medical Center | Omaha, NE | 49 | $60.3 million | 0 | $0 |
| Advanced Bioscience Laboratories, Inc. | Kensington, MD | 6 | $59 million | 0 | $0 |
| American Type Culture Collection | Manassas, VA | 2 | $54.9 million | 0 | $0 |
| Temple Univ of the Commonwealth | Philadelphia, PA | 34 | $54.3 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 47 | $54.1 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 16 | $54 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 29 | $51.7 million | 0 | $0 |
| Florida State University | Tallahassee, FL | 15 | $50.5 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 16 | $50 million | 0 | $0 |
| Brown University | Providence, RI | 47 | $49.5 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 35 | $49.4 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 22 | $46.7 million | 0 | $0 |
| Broad Institute, Inc. | Cambridge, MA | 2 | $44 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 35 | $43.2 million | 0 | $0 |
| University of Chicago | Chicago, IL | 34 | $43.2 million | 0 | $0 |
| The Emmes Company, LLC | Rockville, MD | 3 | $39.6 million | 0 | $0 |
| Wits Health Consortium (pty), LTD | Parktown | 13 | $38.7 million | 0 | $0 |
| Georgetown University | Washington, DC | 17 | $38.6 million | 0 | $0 |
| Boston Medical Center | Boston, MA | 28 | $37.6 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 30 | $37.6 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 24 | $36.7 million | 0 | $0 |
| University of Rochester | Rochester, NY | 29 | $36.6 million | 0 | $0 |
| Florida International University | Miami, FL | 28 | $36.2 million | 0 | $0 |
| Fred Hutchinson Cancer Research Center | Seattle, WA | 27 | $35.7 million | 0 | $0 |
| Stanford University | Stanford, CA | 23 | $34.1 million | 0 | $0 |
| Drexel University | Philadelphia, PA | 29 | $33.1 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 16 | $31.2 million | 0 | $0 |
| University of Cape Town | Rondebosch | 23 | $28.7 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 24 | $27.4 million | 0 | $0 |
| Stellenbosch University | Stellenbosch | 18 | $27.2 million | 0 | $0 |
| Beckman Research Institute/city of Hope | Duarte, CA | 3 | $27 million | 0 | $0 |
| University of Texas Med BR Galveston | Galveston, TX | 21 | $26.2 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 13 | $25.3 million | 0 | $0 |
| University of Louisiana at Lafayette | Lafayette, LA | 6 | $25.2 million | 0 | $0 |
| Rockefeller University | New York, NY | 12 | $24.9 million | 0 | $0 |
| Henry M. Jackson FDN for the Adv Mil/med | Bethesda, MD | 11 | $24.9 million | 0 | $0 |
| University of South Carolina at Columbia | Columbia, SC | 26 | $24.7 million | 0 | $0 |
| Miriam Hospital | Providence, RI | 14 | $24.5 million | 0 | $0 |
| SUNY Downstate Medical Center | Brooklyn, NY | 9 | $23.3 million | 0 | $0 |
| New York University | New York, NY | 16 | $23.2 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 14 | $22.4 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 18 | $22.4 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 14 | $22.3 million | 0 | $0 |
| Rutgers University New Brunswick | New Brunswick, NJ | 4 | $21.7 million | 0 | $0 |
| LSU Health Sciences Center | New Orleans, LA | 20 | $21.5 million | 0 | $0 |
| Graduate School of Public Health and Health Policy | New York, NY | 12 | $21.1 million | 0 | $0 |
| University of Miami | Coral Gables, FL | 15 | $21 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 21 | $20.9 million | 0 | $0 |
| Hektoen Institute for Medical Research | Chicago, IL | 6 | $20.7 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 14 | $20.7 million | 0 | $0 |
| Public Health Foundation Enterprises | City Of Industry, CA | 14 | $20.5 million | 0 | $0 |
| Precision Bioservices, Inc. | Frederick, MD | 1 | $20.4 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 2,390 | $2,510,560,756 | 0 | $0 |
| 2024 | 2,631 | $2,558,825,849 | 0 | $0 |
| 2023 | 2,612 | $2,572,789,703 | 0 | $0 |
| 2022 | 2,626 | $2,776,015,145 | 0 | $0 |
| 2021 | 2,607 | $2,824,131,199 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.